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MEDICAL STUDENT RESEARCH OPPORTUNITIES 
A number of competitive scholarship programs are avail-
able to assist in funding exceptional projects in health care
and medicine, including diversity targeted fellowships,
the Jean L. Fourcroy M.D. Research Award, Health Services
Scholarships, the Lazarus Family Scholarship Program, and
the WT Gill Fellowship, among others.
In 2020, 22 students won a Gill Summer Research
Fellowship and 65 students received a Health Services
Scholarship, which are internally funded programs that
provide stipend support for medical student research in the
summer.
For a list of SMHS student research funding opportunities,
timelines, and application tips visit the website smhs.gwu. 
edu/research/research-workforce/medical-student-research/ 
medical-student-funding-opportunities. 
CHAUDHRY RECEIVES 2020 SPECK AWARD 
Sharjeel Chaudhry, MD ’20 
The 2020 recipient of the ecipient 
of the annual Doris DeFord 
Speck, BA ’41, and George 
Speck, MD ’41 Endowed Prize for 
outstanding accomplishments 
in medical student research was 
Student Medical Research was 
Sharjeel˛Chaudhry,˛MD˛’20. Chaudhry 
demonstrated an exceptional 
record of research accomplishment 
throughout his years at medical 
school. Chaudhry also received the 
prestigious Sarnoff Cardiovascular 
Fellowship, which supported his 
research on the role of coagulation 
factor XII in arterial clot formation 
at Beth Israel Deaconess Medical 
Center under the mentorship of
Robert Flaumenhaft. This work led 
to several frst author and co-author 
publications, presentations at 
national meetings, and supported 
the award of an additional $1 

















Omega Alpha honor society in
support of his research. He also
received a Beaumont Research
Award for outstanding research
accomplishments
Neil Almeida, MSIV 
METEOR PROGRAM 
The Mentored Experience to
Expand Opportunities in Research
(METEOR) program is a competi-
tive fellowship for underrepresent-
ed-in-medicine students. For more
































Research plans were extensively
disrupted this year due to the
COVID-19 epidemic   However, medical
students demonstrated considerable
ingenuity and fexibility in modifying
plans to involve research goals that
could be accomplished remotely  In
addition, as shown in this photo of
students participating in collecting
samples for laboratory testing, medical
students were extensively involved in
community outreach and support to
Washington, D C , residents affected by
the epidemic 








will have a 
chance to 
build on his 
Guido Pelaez, MSIII 
passion for 
research after being chosen for the 
American Society of Hematology 
(ASH) 2020 Minority Medical 
Student Award Program. Pelaez 
is investigating ways to improve 
antibody-directed immunotherapy 
in B-cell lymphoproliferative disease 
under the supervision of Alejandro 
Villagra, PhD, assistant professor 
of biochemistry and molecular 
medicine at SMHS and a researcher 
in the GW Cancer Center, and 
Christopher Hourigan, MD, DPhil,
an investogator at the National 












given to the 
Keirsten Snyder, MD ’20 
graduating 
senior who submits the best scientifc 
paper based on original research. 
WT GILL FELLOW 
Noor Diab, MSII, BS ’19, won 
the 2020 WT Gill Fellowship 
to continue her research on 
the epigenetic regulation of
cancer pathogenesis, under the 
mentorship of Katherine Chiap-
pinelli, PhD, assistant professor 
of microbiology, immunology,
and tropical medicine This work 
was initiated while Diab was an 
undergraduate at GW and the 
picture (on left) above shows 
her in the lab prior to COVID-19 
masking precautions  
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Beaumont Society President’s Letter 





i c a l  s t u d e n t s 
at The George
Washington Zachary Falk, MSII 
University 
(GW) School of 
Med ici ne a nd 
Health Sciences 
(SMHS), we, the 
co-presidents
of the William
H . B e au mont 
Medical Zoe Shancer, MSII 
Research Honor 
Society, proudly
present the 2021 edition of Fusion.
The ofcial research journal of the
GW SMHS, Fusion is a student-led
publication that aims to circulate
the research achievements of GW
medical students to provide a forum 
to communicate their findings and
also to illustrate the broad spec-
trum of research conducted at GW.
This edition received over 50 sub-
missions for publication, which far
surpasses the previous record high
for a single year, which is a testa-
ment to student engagement and a
burgeoning research environment
at our institutions. We believe that
the rich diversity of opportunities in 
research ofered at GW is refected
in the various disciplines represented 
in this edition, which include work in 
basic science, clinical medicine, trans-
lational research, medical education,
public health, and health policy. 
This year especially, we are hum-
bled and inspired by the efforts of
our SMHS colleagues, who not only
navigated the typical challenges in
conducting research but also had to
contend with the COVID-19 pan-
demic that has so greatly afected us
all. Abstracts were submitted from
students of each of the four MD classes
and several submissions directly inves-
tigated the impact of COVID-19 on
clinical practice, which demonstrates
the fexibility and determination of
both the students and their principal
investigators in adapting to the rapidly
evolving research landscape and pro-
ducing quality work that will beneft
our society.
While we are disappointed that
2020 forced us to miss the in person 
interactions of last spring’s Medical
Student Research Day, which was
changed to an on-line format, we
are pleased that Beaumont was able
to adapt and remotely deliver our
workshop talk series for the frst year 
class and plan to develop 2021 Medical
Research Day into an interactive
and virtual format. These outlets
are essential to the development and 
refnement of research skills for mem-
bers of all classes and we are delighted
to play a role in this process. It is clear 
that in recent years, the trajectory of 
student involvement in research has 
decidedly increased, which is strong 
evidence that GW is committed to
providing opportunities for its stu-
dents and cementing its reputation as 
a university entrenched in investiga-
tion and discovery. 
We would like to thank our men-
tors, especially our faculty advisor
David Leitenberg, MD, PhD, asso-
ciate professor of microbiolog y,
immunology, and tropical medicine at
the GW SMHS, and medical director
of fow cytometry and immunology
at Children’s National Hospital,
and Thomas Kohout, director of
publications at GW SMHS, for their 
guidance and assistance with this pub-
lication. We would also like to thank 
the Fusion co-leaders and editorial
board members (listed in the table of 
contents) for their contributions to
this work. 
We hope you enjoy reading this
edition of Fusion and that you will
consider contributing to the journal
next year! 
Zachary Falk and Zoe Shancer 
Co-Presidents, William
H. Beaumont Medical 




















    
     
 
 
    
 
 
   
 
      














     
 
 
















not only to our
p a t i e n t s  b u t  
also in our sig-
n i f ica nt con -
t r ibut ion s  to Alice Chen, MSI 
t he  a d v a nce -
ment of science




tif ic research, 
the crucial link
Isabel Park, MSI b e t w e e n  o u r  
modern knowl-
edge of medicine and the intricacies 
of patient care would simply not exist.
Here at the George Washington
University (GW) School of Medicine 
and Health Sciences (SMHS), research
plays an everyday role in the lives of 
our students as they work to improve 
health care in numerous ways, all
while moving one step closer to
solidifying their own careers as future
physician-scientists. 
As co-directors of the Fusion
Editorial Board, we are pleased to
present the 2021 edition of Fusion, a 
student-run research publication that
highlights the diversity of research
conducted by our very own med-
ical students at GW SMHS. The
articles presented in this journal
span a wide range of research dis-
ciplines, including basic science,
clinical medicine, public health, 
among others. As a research journal, 
Fusion’s primary goal is to provide an 
outlet through which students have
the opportunity to proudly showcase 
their research to their peers and the 
general GW community. Beyond
that, Fusion aims to fulfll the goals 
of the broader William H. Beaumont 
Medical Research Honor Society,
which serves as a forum for students 
to learn about peer research and
share research experiences with one
another. This year, the top Fusion
abstracts were selected to receive
the prestigious William Beaumont
Research Award and present their
research at GW Medical Student
Research Day held in May. This initia-
tive is designed to further exemplify 
the accomplishments of our students 
and represent their commitment to
advancing the health care feld in dif-
ferent areas of focus. 
The breadth and depth of stu-
dent research evident in our quality
abstract submissions speaks to the
diverse interests of GW medical stu-
dents, and we hope readers become
inspired to develop research interests
of their own and join the fourishing 
GW SMHS research community in
the near future. We also hope that
this journal initiates more discourse 
surrounding the importance of novel 
translational and clinical research and
its impact on health care overall. 
This edition would not have been 
made possible without the collective 
help and support of several distin-
guished people. We would like to give
special thanks to our mentor David
Leitenberg, MD, PhD, associate
professor of microbiology, immu-
nology, and tropical medicine at the 
GW SMHS, and medical director
of fow cytometry and immunology
at Children’s National Hospital, for
his guidance as senior researcher and 
advisor of Fusion. We would also like 
to thank Thomas Kohout, director
of publications at GW, SMHS, and
Beaumont Society Co-Presidents
Zachary Falk and Zoe Shancer, for
their continued support and involve-
ment with the publication of this edi-
tion. We are grateful to the Editorial 
Board members (listed on the Table of
Contents) for their eforts and contri-
butions to the journal. 
We hope you enjoy this edition
of Fusion. We encourage you to con-
tribute to the journal in our next issue! 
Co-Directors: 
Alice Chen, MSI
Isabel Park, MSI 
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David Leitenberg MD, PhD, associate
professor of microbiology, immunology, and
tropical medicine at SMHS, and medical
director of fow cytometry and immunology
at Children’s National Hospital 
Performance Inspite of the Pandemic 
To say it has been a challenging year 
is an understatement. The COVID-19
pandemic affected our personal
and professional lives in a myriad of 
ways. This was especially true of our 
medical students pursuing research
activities. Because of COVID-19-
related restrictions on student access
to laboratory and clinical facilities,
as well as changes in clinical practice 
which afected patient participation
in clinical trials, carefully considered
research plans were significantly
afected if not disrupted all together. 
In light of these challenges, I am 
very proud of the research accomplish-
ments described in this year’s edition 
of Fusion. Students demonstrated
remarkable f lexibility and adapted
to COVID-19-related restrictions
on research activity by focusing on
what was feasible and changing plans 
accordingly. For example, students
developed new skills in informatics
and applied that to the development 
and statistical analysis of clinical
data-bases as well as to the analysis
of genomic and proteomic data. I was 
particularly struck by how our stu-
dents responded to the pandemic by 
participating in COVID-19-related
community health eforts combined 
with COVID-19-related research.
Several of our students were instru-
mental in developing databases to
collect clinical and laboratory infor-
mation related to COVID-19-related 
illnesses and response to therapy.
Some of this research has already
been assembled and published in peer-
reviewed journals and information
continues to be collected and analyzed
in ongoing longitudinal research. 
As can be seen in the pages of
Fusion, medical student research
activity at GW is thriving and refects
a broad range of research interests
including basic science research,
clinical research, as well as research
in public health and health policy.
Data from our most recent graduating
class, indicated that 89% of students 
participated in research while a
student in medical school, and 65
percent of students report publishing 
a peer-reviewed manuscript, which
compares to a national average of
55%. This is a credit to the eforts of 
our students and very importantly our
faculty mentors, who are essential for 
this productivity. Congratulations to 
all for your success! 
David Leitenberg MD, PhD
associate professor of microbiology, 
immunology, and tropical medicine 
at SMHS, and medical director of 
fow cytometry and immunology 






























































































 Basic Science 
CRISP-view: A Database of Functional 








Song,1 Yuan Gao,1 Tyson Dawson,1 Lumen
Chao,1 Wubing Zhang,1 Dian Li,1 Jijun Yu,1 
Zexu Li,1 Teng Fei,1 Wei Li1 
ADVISOR: Wei Li1 
1 Center for Genetic Medicine Research,
Children’s National Hospital 
T he pa i r i n g of  C R ISPR /C a s9 
gene editing with next-generation
sequencing technology has enabled
the scientific community to amass
large volumes of genetic knock-out
data on numerous cancer cell lines,
particularly within the last decade. As
a result, computational methods can
be applied to correlate cell survival
and proliferation with individual
genes across a cancer cell’s entire
genome.1 This presents a major oppor-
tunity to probe large-scale genetic
data for potential therapeutic targets.
However, efectively analyzing and
comparing these immense datasets
poses a signifcant challenge.
T he  Mo d el - ba s e d  A n a l y s i s  
of Genome-w ide CRISPR/Cas9 
Knockout with Visualization of
CRISPR Screens (MAGeCK-VISPR)
is an algorithm and visualization tool
previously developed to determine
novel essential genes and pathways
from CRISPR screening experi-
ments.2 It assigns a numerical “beta-
score” to genes in order to rank
their essentiality in cell survival and
proliferation.2 MAGeCK-VISPR is
a downloadable software which can
be executed on the command line,
and it is currently one of the most
favored and highly cited analytical
models used for this purpose. The
aim of this project was to leverage this
software to build a comprehensive,
standardized database of CRISPR
screening data for the exploration
and visualization of functional genes
across multiple cancer types. 
Raw data was retrieved from pub-
licly-available genome-wide CRISPR
screening data sets and was processed
using the MAGeCK-
VISPR algorithm. We
CRISPR screening data to date.3 
The construction of CRISP-view 
ofers a rich landscape of genetic data 
on numerous cancer cell lines. The
standardization of analysis from raw 
data sets, which allows comparability 
between previously incomparable
samples, as well as the expansive
volume of data are major strengths
providing opportunity for further
investigation. Future work will apply 
data mining and machine-learning
approaches to this accumulation of
genetic “big data” to better under-
stand cancer genetics and search for 
therapeutic targets. 
performed systematic The construction of CRISP-view offers a rich 
analysis on all data sets
to assign nu merica l landscape of genetic data on numerous
scores for the deter-
mination of essential cancer cell lines. 
genes. All samples were
annotated with fields
for cell line, organism,
treatment, controls, and sgRNA
librar y used for knock-out. The
data was organized and uploaded
into a publicly available database
containing 10,321 human samples
and 825 murine samples from 167
papers as of September 2020. Data is
presented on a web-interface which
allows researchers to search by cell
line, tissue type, and treatment con-
ditions. Positively and negatively
selected genes are ranked by beta-
scores computed by the MAGeCK-
VISPR algorithm, and can be easily
visualized along with quality control
metrics and sample metadata on the 
interface. This database, entitled
CRISP-view, currently represents
the most comprehensive database of
REFERENCES: 
1. Xing H, Meng LH. CRISPR-cas9: a
powerful tool towards precision medi-
cine in cancer treatment. Acta Phar-
macol Sin. 2020;41(5):583-587. doi:10.1038/ 
s41401-019-0322-9 
2.  Li W, Köster J, Xu H, et al. Quality
control, modeling, and visualization of
CRISPR screens with MAGeCK-VISPR.
Genome Biol. 2015;16:281. Published 2015 
Dec 16. doi:10.1186/s13059-015-0843-6 
3. Cui Y, Cheng X, Chen Q, et al. CRISP-
view: a database of functional genetic
screens spanning multiple phenotypes
[published online ahead of print, 2020
Oct 3]. Nucleic Acids Res. 2020;gkaa809. 
doi:10.1093/nar/gkaa809 
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(3 Variations in PIEZO1 rs62048221 Associated with  








Kristina M  Pond,2 
Rachel Schwartz,1 
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4 Cumming School of Medicine, University
of Calgary, Alberta, Canada
5 Binghamton University State University of
New York 
Osteoporosis is a chronic disease
characterized by low bone density,
disrupted bone microarchitecture,
and an increased risk for fractures.1
W h i le epidem iolog ica l st ud ies 
have linked skeletal loading with
osteogenic responses, insufficient
research has explored the molecular
m e c h a n i s m s  u n d e r l y i n g t h e  
mechanical forces inf uencing bone
mineral density (BMD).1,2 Several 
genetic va r ia nts of PIEZO1, a  
mechanically activated ion channel,
have been associated with decreased
BMD and increased fracture risk.2,3 
The purpose of this study was to
explore musculoskeletal phenotypes
associated with the PIEZO1 single
nucleotide polymorphism (SNP),
rs62048221, in two cohorts of healthy
young adults. 
Cohorts: The Assessing Inherited
Markers of Metabolic Syndrome in
the Young (AIMMY) was comprised
of the University of Calgary subgroup,
with healthy Caucasian young adults
(n=111; 61 males, 50 females; ages
18-35) and the Howard University
subgroup with African American
young adults (n=75; 21 male, 54 female,
ages 18-25) who were recruited as
part of a study to identify genetic
variants associated with risk factors
for metabolic syndrome. Functional
Single Nucleotide Polymorphism
Associated with Human Muscle
Size and Strength (FAMuSS) was
comprised of healthy young adult
Caucasians (n=370; 148 male, 222
female, ages 17-40) who participated
in a strengthening program of their
non-dominant (ND) arm for three
months.
Genotyping: This study used the
Applied Biosystems QuantStudio
7 Flex Real-Time PCR System and
Applied Biosystems Taqman Allelic 
Discrimination Assays in genotyping
the FAMuSS and AIMMY cohort
DNA samples. Statistical Analysis: All
SNPs were tested for Hardy Weinberg
e q u i l i br i u m  ( H W E ),  a nd  a g e  
adjustments were made for each result.
Analysis of covariance (ANCOVA),
using additive genetic models, was
used to test relationships among
SNP genotypes and phenotypes for 
bone quality. Statistically signif cant
associations under went post-hoc
pairwise comparisons and p-values
were adjusted using the Sidak method.
IRB: This study was approved by
the Children’s National Hospital
Institutional Review Board. 
The genotype distribution for
rs62048221 of PIEZO1 was in Hardy
Weinberg equilibrium in the FAMuSS
and HU-AIMMY cohorts. Among
fema les in the FA MuSS cohort,
homozygous variants in rs62048221
were significantly correlated with
lower baseline one arm strength
(p=0.0161) and percent change in one
arm strength (p=0.0214) in the non-
dominant arm. These associations
were not found in ma les in the 
FAMuSS cohort. In the AIMMY
cohort, the TT genotype of rs62048221
in females was associated with a lower
hip circumference compared to 
heterozygous females (p=0.0298).
CONCLUSIONS: This study expands
the known role of the PIEZO1 SNP
rs62048221 in musculoskeletal health
and bone development. The T allele
of rs62048221 has been associated
with decreased BMD in UK Biobank
samples.2 This study demonstrated a 
new association between the T allele
and baseline one arm strength and
percent change in one arm strength
in the non-dominant arm among
fema les in the FA MuSS cohort.
This association was not observed
for males in the FAMuSS cohort
nor among males or females in the
AIMMY cohort. The decrease in arm
strength may help explain the results
of past researchers, who associated
polymorphisms in mechanosensitive
genes with decreased distal radius and
forearm BMD.4,5 Further research is 
warranted to explore the biological
mechanisms underlying the inf uence
of rs62048221 on BMD. Elucidation of
PIEZO1 and other genetic variants
that impact bone mineral density
would be useful in planning exercise
and care regimens for those at higher
risk of fracture through their genetic
variants. 
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Reproducibility of RNA-Seq Methods in Evaluating  
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Cardiovascular disease remains 
the major cause of death in devel-
oped countries, with atherosclerosis
leading to approximately 650,000
myocardial infarctions (MI) each
year in the United States.1 While
the current diagnostic gold standard 
for coronary artery disease (CAD)
is coronary angiography via cardiac
catheterization, less invasive blood
tests identifying a regulatory T-cell
(Treg) imbalance have shown impres-
sive sensitivity and specificity for
CAD.2 Whole blood RNA analyses
via single-molecule next-generation
sequencing (NGS) of RNA (RNAseq)
have identifed transcripts associated 
with CAD (TRACs) that illustrate an
mRNA signature of a Treg-like defect
in CAD patients (Figure 1). Results
have been variable, however, based on
the specifc single molecule sequencer
product employed. The prospect of
an accurate and reliable blood test
to predict the development of ath-
erosclerosis excites many and would 
fundamentally alter the diagnostic
landscape for CAD. 
FIGURE: Schematic representation of Treg-related TRACs identifed by RNAseq  
The objective of the study was
to determine the degree of repro-
ducibility among the primary tech-
niques previously used to identify and
quantify the Treg imbalance under-
lying atherosclerosis. Specifically,
we examined the single molecule
sequencers from SeqLL and Illumina.
Determining the degree of repro-
ducibility of these sequencers would 
enable investigators to d iscern 
superior techniques and ultimately
empower clinicians and to make use 
of the most reliable methods. 
W hole blood R NA was a na-
lyzed by single-molecule next-gen-
eration sequencing (NGS) of RNA
(RNA-Seq) to identify TRACs in
a discovery group and a validation
group presenting for coronary cath-
eterization. Whole blood RNA was
depleted of ribosomal RNA (rRNA) 
and then sequenced on a SeqLL Single
Molecule Sequencer. The resulting
short reads were aligned to the human
transcriptome and the number of
reads per kilobase of exon per mil-
lion (RPKM) was determined and
compared between groups by a com-
bined fold-change/p-value flter. This
model was replicated in an additional 
study, and an identical design was
undertaken using a sequencer from
Illumina, and transcript reads were
analyzed by sequencer product. 
Sequencing identifed a profle of 
Treg imbalance in patients with even 
Continued on p. 10 
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mild coronary stenosis (>20%) as con-
frmed on coronary angiography. The 
SeqLL platform identified a subset
of 39 transcripts highly-associated
with CAD that were replicated in a
follow-up study (p<0.001), while the 
Illumina follow-up study displayed
minimal meaningful overlap with its 
initial fndings. 
Conclusion: The SeqLL sequencing
platform of amplifcation-free, single 
molecule sequencing seems to be
more reproducible than the amplif-
cation-dependent Illumina NextSeq.
Future investigations will be directed
toward establishing a clinically rel-
evant amplifcation-free method of
quantifying RNA in patient blood. 
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Screening for Small Molecule Modulators of RIG-I and  
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The vertebrate immune system has 
receptors that recognize a wide
range of viral nucleic acids during
an infection and elicit a robust anti-
viral response. Retinoic acid-induc-
ible gene-I (RIG-I) and Melanoma
Differentiation-Associated pro-
tein 5 (MDA5) are two such pattern
recognition receptors (PRRs) that
stimulate a type I interferon (IFN)
response against a variety of double
stranded ribonucleic acid (dsRNA).1 
While proper functioning of these
receptors is critical for reducing viral
spread, mis-regulation of MDA5 or
RIG-I can result in autoinfamma-
tory conditions such as Systemic
Lupus Erythematosus (SLE), Aicardi-
Goutières syndrome (AGS), and
Singleton-Merten syndrome (SMS).2 
Previous research suggests that
the ATPase active site of these recep-
tors acts as an allosteric modulation
FIGURE: 
site, playing a role in altering the
confirmation of RIG-I and MDA5
and thereby afecting their signaling
activity.3 Our group has examined sev-
eral mutations in the ATPase site that
result in loss of the ATPase activity.
While the dsRNA binding capabili-
ties remained intact, these mutants
displayed signifcant changes in sig-
naling activity. Half of these mutant
proteins showed a hyper-signaling
phenotype, while the other half dis-
played a complete loss of signaling.
This fnding has been our rationale
for targeting the ATPase site with
small molecule intervention. In this
study, we have used a biochemical
assay to screen for thousands of small
molecules to identify potential hits
that inhibit the ATP hydrolysis capa-
bilities of RIG-I and MDA5. These
hits were then further characterized
using cell-signaling and cell-free
assays to delve into the mechanism
of inhibition. More specifcally, these
assays served to identify whether
downstream mediators in the RIG-I
and MDA5 pathways were inhibited
or activated by the compounds.
MDA5 and RIG-I were recom-
binantly expressed in a strain of E.
coli. These cells were lysed, and the
proteins were purifed using afnity
and size-exclusion chromatography.





















































   
  




RNA polymerase and gel electropho-
resis. The ATP hydrolysis assay was
implemented in screening thousands
of small molecules from various
libraries. The reaction was initiated
when a mixture of RNA and ATP was
added to pre-incubated protein and
compounds. The optical densities of
the samples were then measured to
gauge ATP hydrolysis. After initial
screening, electrophoretic mobility
shift assay (EMSA) was performed
by incubating MDA5, RIG-I, RNA,
and the small molecule compounds.
Gel electrophoresis with SYBR gold
staining was used to determine how
these compound inf luence RNA
binding. Finally, IRF3 dimerization
(downstream transcription factor)
was studied to assess whether the
compounds upregulate or down-
regulate the MDA5/RIG-I signaling
pathway. 
Compou nds were nu mbered 
rather than named to maintain con-
fidentiality. After the compound
screening, “hits” were classified as
compounds that were successful in
inhibiting ATP hydrolysis (Figure
A). The EMSA showed that some
compounds were able to interrupt
protein-RNA binding at high doses
of the compound (Figure B). IRF3
dimerization occurs only when the
protein and RNA are both present,
and dimerization indicates an acti-
vation of the downstream signaling
process (Figure C). Illustrated in
Figure D, certain compounds were
able to interrupt the IRF3 dimeriza-
tion, indicating that these compounds
were successful in inhibiting the
MDA5 signaling cascade. Compounds
such as Compound 17 were especially
potent in inhibiting this step even at
lower concentrations.
Conclusions: Among the hits were
inhibitors of several known enzymes
such as certain dehydrogenases,
Cytochrome P40, topoisomerase, and 
cyclooxygenase. Identifying inhibi-
tors these pathways has implications
in therapy for autoinf lammatory
conditions. Future experiments will
implement additional cell-based
assays to further characterize the hits.
REFERENCES 
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The well documented plasticity of the
mammalian brain suggests a role for
environmental experience in modu-
lating brain development.1 Indeed,
environmental enrichment (EE) has
been championed as a robust and non-
invasive approach to augment white
matter health.1,2 This experimental
paradigm, which exposes animals to
increased social interactions, novel
stimuli, and voluntary exercise, is a
powerful promoter of neuroplasticity
that leads to functional improvement 
in neurological injury models, such as
premature birth.1,2 Recent work has
demonstrated that this neuroplas-
ticity increases activity-regulated
changes in myelin forming cells,
including oligodendrocyte precursor
cell (OPC) proliferation, oligoden-
drogenesis, and modulations in the
thickness and number of myelinated
axons.3-5 We previously reported that
early and continuous EE attenuates
cellular, behavioral, and ultrastruc-
tural defcits caused by hypoxic brain
injury by stimulating oligodendro-
cyte maturation, myelination, and
FIGURE: Environmental enrichment increases the thickness of P60 myelinated 
axons in normal development. A) Experimental groups  B) Representative electron 
microscopy image from NX white matter  C) Representative electron microscopy image 
from EE white matter  D) Scatter plot of g-ratios of corpus callosum axons in comparison 
to axon caliber in NX vs EE  E) Qualifcation of myelinated axon number in the corpus 
callosum (n=4 per group)  
functional recovery.1 While the value
of an EE intervention after adult
injury has been demonstrated,2 the 
utility of EE in normal development,
especially in glial development, has
not been fully elucidated. Here, we
aimed to understand whether EE
afects normal developmental myelin-
ation through adulthood. 
Mice were randomly assigned to
be housed in an enriched environ-
ment or standard environment cages.
The enriched environment condition 
consisted of clear Plexiglas cages (24
cm W x 20 cm H x 46 cm L) that
had either wooden blocks or metal
link chains hanging from the roof,
a running wheel, a series of plastic
“habit-trails” of diferent confgura-
tions, and several balls and other
objects spread over the foor. These
objects were changed every 3 days to
preserve novelty. The standard envi-
ronment protocol consisted of smaller
cages (16 cm W x 13 cm H x 37 cm L)
























































mice housed in an enriched environ-
ment had. Furthermore, while control
mice were reared in groups of 2-5
animals per cage, mice housed in an
enriched environment were reared
in groups of 8-12 animals per cage.
Immunohistochemistry and electron
microscopy analysis was performed.
An inclined beam-walking test was
used to examine diferences in sub-
cortical white matter myelination
between experimental and control
groups. The time that it took each
mouse to reach the target at the top
of the inclined beam as well as the
number of foot slips was documented.
Analysis was performed at postnatal
day (P) 60. 
We first assessed the effects of
prolonged EE on OPCs and prolif-
erating OPCs versus normoxic (NX)
controls and found no changes in
oligodendrogenesis in response to
EE. To examine efects of myelination
at the ultrastructural level, we per-
formed electron microscopy analysis
on the corpus callosum of P60 mice.
In comparison to NX mice, EE mice
had axons with thicker myelin, as
indicated by lower g-ratio values
(Figure). Furthermore, enriched mice
had improved motor coordination on
a beam walking test, as demonstrated 
by the decreased number of foot slips.
No significant difference between
groups was noted for the amount of
time that it took to reach the target.
Conclusions: The cellular, ultra-
structural, and behavioral experi-
ments conducted in this study dem-
onstrate that prolonged EE, com-
prised of enhanced exposure to novel 
stimuli, socialization, and locomotor 
activity, can increase developmental 
myelination and lead to functional
improvement in behavior. Hence, EE 
can play a benefcial role in normal
development. Future research should
work towards translating EE proto-
cols into clinical interventions for
improving locomotor function.
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SARS-CoV-2 specifc T-cell Epitopes and in 
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Understanding T-cel l responses
to SARS-CoV-2 is crucial for the
development of vaccines and adop-
tive immunotherapy. The HL A
presentation of antigenic peptides
in particular is essential for gener-
ating robust T-cell responses against
SA RS - CoV-2, which may affect
susceptibility to and severity of
SARS-CoV-2 infection. The pur-
pose of this study was to determine
whether SARS CoV-2-specifc T-cell
epitopes identified in convalescent
patients are predicted to be restricted 
through a wide range of both class
I and class II HLA molecules. The
study also aimed to determine the
stability of SARS-CoV-2 predicted
epitopes. 
T-cell epitope mapping of struc-
tural proteins was done using mini-
pools containing 5–12 peptides each,
with responses measured via IFN-g
ELISpot. Once SARS-CoV-2 specifc
T-cell epitopes were identifed, pre-
dictive algorithms were used to deter-
mine HLA restriction predictions
for each epitope of membrane, spike,
nucleocapsid and envelop proteins.
The predictive algorithms used were
NetMHCIIPan and MARIA, which
provide percent rank scores, normal-
izing prediction scores by comparing
epitopes to a set of random pep-
tides.1,2 The stability of SARS-CoV-2
predicted epitopes was determined
through identifcation of and compar-
ison to known SARS-CoV-2 genetic
variants in available literature.
T- cel l  e pito p e s  w it h i n  t he  
C-terminus of membrane protein
were identifed at amino acids (AA)
144–163 and 173–192, which were
recognized by 8 and 6 convalescent
donors respectively. Mapping of spike
epitopes demonstrated three regions
at AA 57-75, 205–224, and 449–463,
which were recognized by 3 donors.
Mapping of nucleocapsid epitopes
revealed two regions at AA 257-271
and 313-335, which were recognized
by three donors.
A ll membrane epitopes were 
pred icted to be M HC Class II 
restricted. In silico analysis sug-
gested restriction of these epitopes
through HLA-DR11, DR7, DQ3,
and DQ7. Nucleocapsid epitopes
between AA 257-271 were predicted 
to be Class II restricted. Strong
binders included HLA-DPA1*02:01
and HLA-DPB1*14:01. Two nucleo-
capsid epitopes between AA 313-335
were Class I restricted. Five spike




One known SARS-CoV-2 genetic
variant within membrane protein,
T175M, overlaps with predicted 
peptide 44. One nucleocapsid varia-
tion, T271I, overlaps with predicted
epitope 65. Two known spike muta-
tions overlap with predicted epitopes:
N74K mutation with peptide 15 and
S221W with peptide 53.
Conclusions: In silico analysis pre-
dicted HLA restriction of membrane
protein epitopes through al leles
which are present in approximately 
50% of the population.3 Identified
membrane, nucleocapsid, and spike
epitopes appear to be genetically
stable, as known variants are point
mutations that do not overlap with
anchor residues. Further study is
needed to better understand the bio-
logic activity of SARS-CoV-2 T-cells
of various restrictions. It will be
critical to determine if there are risk
associations with specifc HLA types.
REFERENCES 
1. Chen B, K hodadoust MS, Olsson N,
Wagar LE, Fast E, Liu CL, Muftuoglu
Y, Sworder BJ, Diehn M, Levy R, Davis
MM, Elias JE, Altman RB, Alizadeh AA. 
Predicting HLA class II antigen presenta-
tion through integrated deep learning.
Nat Biotechnol. 2019 Nov;37(11):1332-1343.
doi: 10.1038/s41587-019-0280-2. Epub
2019 Oct 14. PMID: 31611695; PMCID:
PMC7075463. 
2. Reynisson B, Barra C, Kaabinejadian
S, Hildebrand WH, Peters B, Nielsen
M. Improved Prediction of MHC II
Antigen Presentation through Integra-
tion and Motif Deconvolution of Mass
Spectrometry MHC Eluted Ligand Data. 
J Proteome Res. 2020 Jun 5;19(6):2304-2315.
doi: 10.1021/acs.jproteome.9b00874. Epub
2020 Apr 30. PMID: 32308001. 
3. Klitz W, Maiers M, Spellman S, et al. New
HLA haplotype frequency reference stan-
dards: high-resolution and large sample
typing of HLA DR-DQ haplotypes in a
sample of European Americans. Tissue
Antigens. 2003;62(4):296-307. 
BASIC SCIENCE
Table 1: Identified Class II Epitopes in Membrane, Nucleoprotein, and Spike proteins and predicted HLA restrictions 
Membrane 
Peptide sequence Amino acid Subject HLA-DRB1 HLA- HLA-DRB4 HLA- HLA-DQA1 HLA-DQB1 HLA-DPA1 HLA-DPB1 
location DRBJ DRBS 
LRGHLRIAGHHLGRC 144-159 257 07:01, 11:04 02:02 01:03 02:01, 05:01 03:01, 03:03 01 :03, 02:01 03:01, 03:03 
262 07:01, 11:01 02:02 01:01 02:01, 05:01 02:02, 03:01 01 :03, 03:01 04:01, 11:01 
265 11:04, 15:02 02:02 01 :01, 01 :03 01:02 01 :03, 05:01 03:01, 06:01 01 :03, 02:01 02:01, 14:01 
270 11:04, 15:01 02:02 01 :02, 05:01 03:01, 06:02 01 :03, 02:01 04:01, 14:01 
LRIAGHHLGRCDIKD 148-163 257 07:01, 11:04 02:02 01:03 02:01, 05:01 03:01, 03:03 01 :03, 02:01 03:01, 03:03 
265 11:04, 15:02 02:02 01 :01, 01 :03 01:02 01 :03, 05:01 03:01, 06:01 01 :03, 02:01 02:01, 14:01 
SRTLSYYKLGASQRV 173-188 262 07:01, 11:01 02:02 01:01 02:01, 05:01 02:02, 03:01 01 :03, 03:01 04:01, 11:01 
265 11:04, 15:02 02:02 01 :01, 01 :03 01:02 01 :03, 05:01 03:01, 06:01 01 :03, 02:01 02:01, 14:01 
269 12:01, 15:01 02:02 01:01 01:01 01 :02, 05:01 03:01, 05:01 01 :03, 01 :03 02:01, 04:01 
270 11:04, 15:01 02:02 01 :02, 05:01 03:01, 06:02 01 :03, 02:01 04:01, 14:01 
273 03:02, 16:02 01:62 01 :01, 01 :03 02:02 01 :02, 04:01 04:02, 05:02 02:02, 02:02 01:01, 01:01 
275 01 :01, 03:01 01:01 01:01, 01:03 01 :01, 05:01 02:01, 05:01 01 :03, 01 :03 02:01, 02:01 
SYYKLGASQRVAGDS 177-192 262 07:01, 11:01 02:02 01:01 02:01, 05:01 02:02, 03:01 01 :03, 03:01 04:01, 11:01 
269 12:01, 15:01 02:02 01:01 01:01 01 :02, 05:01 03:01, 05:01 01 :03, 01 :03 02:01, 04:01 
273 03:02, 16:02 01:62 01:01, 01:03 02:02 01 :02, 04:01 04:02, 05:02 02:02, 02:02 01:01, 01:01 
275 01:01, 03:01 01:01 01:01, 01:03 01 :01, 05:01 02:01, 05:01 01 :03, 01 :03 02:01, 02:01 
LGASQRVAGDSGFAA 181-195 275 01 :01, 03:01 01:01 01:01, 01:03 01 :01, 05:01 02:01, 05:01 01 :03, 01 :03 02:01, 02:01 
Nucleoprotein 
KPRQKRTA TKAYNVT 257-271 276 04:01, 07:01 01:01 01:03 03:01, 05;05 03:01, 03:02 02:01, 02:01 14:01, 14:01 
AFFGMSRIGMEVTPS 313-327 270 11:04, 15:01 02:02 01 :02, 05:01 03:01, 06:02 01 :03, 02:01 04:01, 14:01 
Spike 
PFFSNVTWFHAIHVS 57-71 259 03:01, 13:01 01:01 01:03 01 :03, 05:01 02:01, 06:03 01 :03, 01 :03 04:01, 04:01 
NVTWFHAIHVSGTNG 61-75 259 03:01, 13:01 01:01 01:03 01 :03, 05:01 02:01, 06:03 01 :03, 01 :03 04:01, 04:01 
SKHTPINLVRDLPQG 205-219 291 03:01, 04:01 01:01 01:03 03:01, 05:01 02:01, 03:02 01 :03, 01 :03 02:01, 03:01 
PINLVRDLPQGFSAL 209-223 273 03:02, 16:02 01:62 01:01, 01:03 01 :02, 04:01 04:02, 05:02 02:02, 02:02 01:01, 01:01 
291 03:01, 04:01 01:01 01:03 03:01, 05:01 02:01, 03:02 01 :03, 01 :03 02:01, 03:01 
YNYL YRLFRKSN LKP 449-463 291 03:01, 04:01 01:01 01:03 03:01, 05:01 02:01, 03:02 01 :03, 01 :03 02:01, 03:01 
Red: strong binder (<2). Green: Weak binder (2-10) 
Table 2: Identified Class I Epitopes in Nucleoprotein and predicted HLA restrictions 
Peptide sequence Amino acid Subject HLA-A HLA-B HLA-C 
location 
MSRIGMEVTPSGTWL 317-331 270 
24:02, 26:01 40:01, 44:os· 02:02, 03:04 
GMEVTPSGTWL TYTG 321-335 270 
24:02 26:01 40:01 44:os• 02:02 03:04 
Red: strong binder (<2). Green: Weak binder (2-10). * Predicted B*44:05 peptide: GMEVTPSGTW 
15 
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The Association of H-Index and Academic Rank  
Among Full-Time Academic Orthopaedic Trauma  
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R e s e a r c h  p r o d u c t i v i t y  h a s  
traditionally been a key determinant
for professional advancement within
academic medicine.1 In the past,
productiv it y has been assessed 
using simple numeric measures H-indices of 322 orthopaedic trau-
such as publications and citation matologists from 57 OTA fellowship
counts. However, these metrics only programs were organized and calcu-
measure quantity and are unable lated. Additionally, the total number
to provide insight regarding the
quality of a researcher’s publications.
In recent years, there has been a trauma association [O]ur fndings indicate that H-index, number
push to move past these simple (OTA) fellowship
measures of productivity.1,2 J. E. prog ra ms i n t he of citations, and number of publications
Hirsch first proposed the H-index United States. The
in 2005 as a bibliographic metric study population are strongly correlated with academic rank
to objectively assess the quality of wa s constr ucted 
a researcher’s publications.3 While by q uer y i n g t he among full-time orthopaedic trauma surgeons 
originally developed for use in the Orthopaedic 
natural sciences,3 its association Trauma Association affliated with fellowship training programs. 
w it h academ ic r a n k h a s si nce (OTA) website to
been validated by studies within a obtain a complete
variety of both medical and surgical record of all OTA-afliated ortho- of publications, academic rank, and
specialties.4,5 To our knowledge, no paedic traumatolog y fel lowship fellowship training pedigree were
prior studies have evaluated academic training programs. A total of 62 also collected. Data normality was
i mpact by or thopaed ic trau ma programs were identifed. For each assessed using the Shapiro-Wilk
surgeons on faculty at fellowship program, the department website was test. Variance was assessed using
training programs. The purpose of used to generate a list of faculty mem- Kruskall-Wallis test for non-para-
this study is to assess the association bers with primary appointments. The metric data that were not normally
FIGURE 1: H-Index versus number of citations and publications plotted on 
logarithmic scale 
between H-index and academic rank
within this cohort. 
This is a cross-sectional study
of full-time orthopaedic surgeons
a f f i l i a t e d  w i t h 
orthopaedic 
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distributed due to skew and outliers.
Post-hoc analysis on non-normally
distributed data was performed using 
Mann-Whitney test with Bonferroni
correction. Median differences for
non-normal data were determined by
Hodges-Lehman estimation. 
Overall, these 322 surgeons have
published 14,822 publications. The
total H-index for this group of sur-
geons is 4,136. Number of publi-
cations is a stronger predictor of
H-index than number of citations (p
< 0.0001). Number of publications,
number of citations, and H-Index
tend to increase with academic rank
(p < 0.001). There exists no signif-
cant trend with respect to afliated
training amongst the various aca-
demic ranks. Orthopaedic trauma
versus other orthopaedic sub-spe-
cialty fellowship training is not a
predictor of academic rank (p 0.11).
There exist no geographical difer-
ences with regards to academic rank
and training afliation (p 0.79). There
is no statistical diference in research
productivity for those with afliated
training pedigree versus those not
afliated with respect to number of
publications (p 0.44), number of cita-
tions (p 0.62), and H-Index (p 0.59). 
In conclusion, our fndings indi-
cate that H-index, number of cita-
tions, and number of publications
are strongly correlated with academic
FIGURE 2: Number of publications by academic rank in box-and-whisker (A) and 
histogram (C) plots  H-index by academic rank in rank in box-and-whisker (B) and 
histogram (D) plots  
rank among full-time orthopaedic
trauma surgeons afliated with fel-
lowship training programs. While
research productivity is not the only
benchmark for achievement in aca-
demic medicine, it has historically
been considered a key determinant
for professional advancement. Our
fndings suggest the H-index may be a
useful metric for evaluating academic
impact within the feld of orthopaedic
trauma surgery. 
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Mean (SD) Median <Ranee) Coefficient of Variation 
Medicare Reimbursement 
Shoulder Arthron!astv 1473.9 (93.55) 1467.93/1353.37-1929.14) 0.06 
Shoulder Hemiarthroolastv 1218.63(77.23) 1212.69(1119.53-1590.95) 0.06 
Proximal Humerus ORIF 894.26(56.53) 887.26(822.65-1159.20) 0.06 
Total Elbow Arthroolastv 1477.3904(96.77) 1467.63(1355.55-l 929.40) 0.07 
Distal Humerus ORIF 943.1146(61.88) 934.22(865.29-1222.0 I) 0.07 
Radial Head ORIF 662.681(43.4 654.365(607.29-850.56) 0.07 
Radial Head Arthroplastv 692.486(45.36) 685.715(635. 78-894.61) 0.07 
Radial Head Excision 515.784(32.85) 5 I0.06(472.55-661.27) 0.06 
Humeral Shaft ORIF 891.187(56.68) 883.535(818.32-1151.96) 0.06 
Humeral Shaft IMN 871.3786(55.43) 864.275(799.55-l 129.60) 0.06 
Olecraoon ORIF 661.4132(42.14) 654.93(606.05-849.00) 0.06 
Clavicle ORJF 729.4216(46.41) 723.335(669.27-940.6 l) 0.06 
Total 919.30(308.62) 862.11( 472.55-1929.40) 0.34 
Medicaid Reimbursement 
Shoulder Arthron!astv I 181.261321.56\ 1136.485/515.5-2219.63) 0.27 
Shoulder Hemiarthroplastv 944.24(244.09) 933.46(515.5-1830.52) 0.26 
Proximal Humerus ORIF 650. 77(189.48) 644.74(211-1333.75) 0.29 
Total Elbow Arthroplastv 1141.79(308.93) l 122.655(463.95-2219.93) 0.27 
Distal Humerus ORIF 676.13(208.64) 684.31(211-1406.02) 0.31 
Radial Head ORIF 483.54(140.66) 486.33(151-978.64) 0.29 
Radial Head Arthroolastv 561.65(166.9' 544.5(242.29-1123.7) 0.3 
Radial Head Excision 396.45(107.6 I) 3 87.54(134-760.84) 0.27 
Humeral Shaft ORIF 664.08(192.34 I 671.92/211-1325.43) 0.29 
Humeral Shaft !MN 676.1(175.25 664.45(211-1299.7) 0.26 
Olecraoon ORIF 497.83(145.75) 502.59(128.88-976.84) 0.29 
Clavicle ORJF 507.6(165.08) 511.5(151-1082.25) 0.33 
Total 701.08(328.41) 612.66(128.88-2219.93) 0.47 
Medicare Wage Index Adjusted Medicaid Reimbursement 
Shoulder Arthroolastv 1083.24/392.91) 98 l .72/537.15-2802.06) 0.36 
Shoulder Hemiarthroplastv 874.96(317.65) 769.3(449.12-2310.85) 0.36 
Proximal Humerus ORJF 603.08(240.22) 550.71(234.97-1683. 73) 0.4 
Total Elbow Arthroplastv 1047.73(391.67) 929.95(483.44-2802.44) 0.37 
Distal Humerus ORIF 624.48(255.01) 579.26(234.97-1774.96) 0.41 
Radial Head ORIF 447.08(175.79) 406.22(18.15-1235.44) 0.39 
Radial Head Arthroolastv 518.2/191.16) 458.66/252.47-1299.43) 0.37 
Radial Head Excision 366. 79/134.89) 326. 74(149.22-960.48) 0.37 
Humeral Shaft ORIF 613.1(236.59) 558.77(234.97-1673.22) 0.39 
Humeral Shaft IMN 624.85(223.74) 564.92(234.97-1640. 74) 0.36 
Olecraoon ORIF 458.96(177.8 I) 417.44(134.29-1233. 16) 0.39 
Clavicle ORJF 470.07(201.98) 440.61(161.15-1366.23) 0.43 
Total 642.94(339.28) 55l.21(134.29-2802.44) 0.53 
Variation in State and Federal Reimbursement in  
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The purpose of this study is to com-
pare MCR and MCD reimbursement
rates for 12 orthopaedic procedures 
performed to treat common frac-
tures of the upper extremity. Upper 
extremity injuries account for approxi-
mately 10% of traumas presenting
to emergency departments in the
United States and represent a signif-
cant source of health care spending.1 
Secondary to both a growing popu-
lation and increasing life expec-
tancy, it is also anticipated that more
Americans will continue to enroll
in Medicare (MCR) and Medicaid
(MCD).2,3 Given the increasingly
large number of patients covered by
government-run healthcare programs,
it is critical that a sufcient number
of orthopaedic surgeons participate
with these payers. However, MCD
is a federal-state program, and the
guidelines put forth by the Centers
for Medicare and Medicaid Services 
(CMS) allow for each state to deter-
mine access and MCD reimburse-
ment rates.4 Large discrepancies have
been reported between MCD and
MCR reimbursement for identical
procedures.5 Such inconsistencies in
reimbursement may act as a barrier to
MCD patients gaining access to timely
orthopaedic care.
Twelve orthopaedic procedures
TABLE 1: Medicaid, Medicare, and Medicare Wage Index Adjusted Medicair 
Reimbursement  Data presented as Mean$ ± SD, MedianS with range, and coeffcient of
variation for reimpbursement 
performed for the treatment of
common upper extremity fractures
were selected for analysis. The 2020
MCR reimbursement rate was col-
lected for each procedure for each
state from the Medicare Physician
Fee Schedule Database. MCD reim-
bursement rates were obtained from
each state’s physician fee schedule
database. Reimbursement rates were
then compared by assessing the ratio
of MDC to MCR, the dollar diference
in MCD to MCR reimbursement, and
the diference per relative value unit
(RVU) to adjust for the diference in
procedure complexity.2,3 The range 
of variation in MCD reimbursement
and MCR wage index-adjusted MCD
reimbursement was calculated, as
well as the coefficient of variation.
Comparisons in reimbursement were
calculated using coefcient of varia-
tion and student T tests to evaluate the
diferences between the mean MCD
and MCR reimbursements. 
There was statistically signifcant
difference in reimbursement rates
between MCR and MCD for all 12
procedures, with MCD reimbursing 
on average 46.5% less than MCR. In
40 states, MCD reimbursed less than
MCR for all 12 procedures. Regarding
the dollar diference per RVU, MCD
paid on average $18.03 less per RVU









































Mean(SD) Median (ranee) ¾ Difference Pvalue Coefficient of Variation 
Dollar Difference between MCD and MCR 
Shoulder Arthroolastv -293.81(316.85) -307. 7(-1020.78-663.33) -34.49/42.41) <0.001 -1.08 
Shoulder 
Hemiarthronlastv -275.95/236.95) -264.42/-809.92-239 .57) -38.07/39.9) <0.001 -0.86 
Proximal Humerus 
ORIF -244.64/183.99) -236.87ff-769.77-174.55)) -51.23/60.62) <0.001 -0.75 
Total Elbow 
Arthro lastv -336.84/305.61) -324.205/-1073.! 1-290.53) -40.73/50.42) <0.001 -0.91 
Distal Humerus ORJF -268.23(208.46) -246.24/-820. I 9- I 84.0 I) -57.64(73.68) <0.001 -0.78 
Radial Head ORIF -180.01/140.5) -155.53/-578.69-l28.08) -52.61/67.6]) <0.001 -0.78 
Radial Head 
Arthro lastv -131.75/167.68) -127.93/-480.96-425.63) -34.27/44.05) <0.001 -1.27 
Radial Head Excision -l20.01/!07.7ll -l20.59(-434.51-99.57) -42.35/56.05) <0.001 -0.9 
Humeral Shaft ORIF -228.29/191.29) -205.21 <-765.32-113.4 n -49.28(64.7) <0.001 -0.84 
Humeral Shaft lMN -196.43(173.71) -193.94(-741.64-l 70.l) -40.14(55.72) <0.001 -0.88 
Olecranon ORIF -164.46(145.65) -l42. I 7(-577.23-127.84) -52.07(83.88) <0.001 -0.89 
ClavicleORIF -222. 79/161.36) -205.58/-649.44-l4l .64) -65.16/85.27) <0.001 -0.72 
Total -221.62/2l1.5n -192.51(-1073.11-663.33) -46.53/62.26) <0.001 -0.95 
than MCR. There was substantial
variation in reimbursement per RVU,
ranging from $69.22 less per RVU
(New Jersey, radial head ORIF) to
$45.47 more per RVU (Illinois, radial
head arthroplasty) for MCD. The
coefcient of variation for MCD reim-
bursement ranged from 0.26 (shoulder
hemiarthroplasty and humeral shaft
IMN) to 0.33 (clavicle ORIF). This is
in stark contrast with the signifcantly
lower variability observed in MCR
reimbursement, which ranged from
0.06 to 0.07 for all procedures.
The findings of this study call
attention to the significant vari-
ability in reimbursement that exists
among state MCD programs for 12
orthopaedic procedures commonly
used to treat fractures of the upper
extremity. This exceeded the varia-
tion seen in MCR reimbursement
for the same group of procedures.
Additionally, MCD reimbursement
was signifcantly lower than MCR for
all 12 procedures. Such discrepancies
may act as a barrier, preventing many
MCD patients from accessing timely
orthopaedic care. Implementing more
uniform and robust reimbursement
TABLE 2: Dollar differences between Medicaid and Medicare reimbursement  Data 
presented as a Mean$ ± SD, MedianS with range and percent difference  Negative 
values indicate lower Medicaid reimbursement when compared to Medicare  
models may increase access to care for
the millions of MCD benefciaries in
the United States. 
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Qualitative Experiences of Person-centered Maternity Care 
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Improving high quality, respectful
maternity care is a global priority
to advance maternal and neonatal
health.1 Globally, mistreatment of
women during maternity care is
TABLE: Participant Characteristics 
Age (years) 
Legal Status 
Time in US (years) 
County 
Undocumented family or friends 
widespread. Recent data from the
United States (US) suggest that one
in six women reported experiencing 
one or more types of mistreatment.2 
Immigrant women, in particular, face
a myriad of assaults to their basic civil 
rights, potentially leading to lower
health status. Despite lower access to 
prenatal care and increased reports of 
discrimination, stigma, and infringe-
ments on reproductive rights, the
maternity care experiences of immi-
grant women remain understudied.
This article extends the literature
of person-centered maternity care
(PCMC) by applying recently vali-
dated measures and frameworks to a 
US context.3, 4 Specifcally, this study 
focuses on Mexican and Chinese
immigrant women, two of the largest 
Mexican Chinese/ Total 
Taiwanese 
n=10 n=8 n=18 
Mean 38 34 4 36 4 
≤30 2 3 5 
31-40 2 4 6 
>40 6 1 7 
Naturalized 1 1 2 
Permanent Resident 0 5 5 
Work Permit 3 1 4 
Overseas Born Citizen 0 1 1 
Undocumented 6 0 6 
Mean 20 11 9 16 4 
LA 5 5 10 
OC 5 3 8 
10 (100%) 3 (37 5%) 13 (72 2%) 
immigrant populations in the U.S. 
The Research on Immigrant 
Health and State Policy Study is a
convergent parallel mixed methods
study examining the lived experiences
of Latino and Asian immigrants in
California. Semi-structured, in-depth
inter views were conducted from
August 2018 to August 2019 with
Mexican and Chinese women living
in Los Angeles or Orange County
who gave birth within the past two
years. Interviews (n=18) were con-
ducted by nine bilingual interviewers,
transcribed, and subsequently coded. 
Coded data were mapped onto the
domains of PCMC. 
Women described several prefer-
ences when establishing prenatal care,
including provider qualifcations, lin-
guistic, and ethnic concordance. Most
Chinese women who actively sought a
specifc provider cited linguistic and 
ethnic concordance as their main
criteria. Across ethnicity, county, and
immigration status, women shared
the expectation that more difficul-
ties arose for those who did not speak 
English.
Almost all participants spoke of
an overall positive experience, yet
the majority of women pinpointed
instances of mistreatment. Negative 
experiences ranged from long wait
times to acts of disrespectful care such
as denial of necessary medical care.
Many women described specifc nega-
tive encounters such as feeling rushed,
judged, and blamed by providers. 
Translation services were often
quoted as unavailable or f lawed.
However, Mexican women, overall,
reported greater ease of accessing
translation services or bilingual pro-
viders compared to Chinese partici-
pants. For women who spoke English 
well, or attended clinics with bilingual
staf or adequate translation services, 





















     
 












language and cultural concordance
were not defining features in their
perception of care. 
Some women utilized informal
support systems to enhance com-
munication such as enlisting a family 
member to assist in translating or
using available technology to over-
come language barriers. Chinese
women, in particular, were more likely
to utilize these strategies to enhance 
their care experience. 
To our knowledge, this study is the
frst to apply concepts of PCMC to a 
US context, particularly among immi-
grant women. Our fndings are in line 
with other research that suggests poor
patient-centered care among commu-
nities of color in the U.S.5 
There is signifcant overlap with
our study findings and the expe-
riences of lower status women in
international contexts. However, it
is also important to highlight areas
that may be uniquely specifc to the 
US immigrant context. These include
judgements related to fertility, lan-
guage challenges, and preferences for 
cultural concordance with providers. 
Understanding immigrant experi-
ences of respectful maternity care can
ofer insight to clinicians and policy-
makers, and contextualize the future 
of patient-centered care research and
its intersection with immigrant life
in the U.S. 
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Economic Impact of Thrombectomy: Relationship of
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In the last five years, mechanical
thrombectomy has revolutionized
the standard of care for patients suf-
fering from acute stroke.1 The cost
of mechanical thrombectomy pro-
cedures has been shown to cost more 
than traditional medical therapy.2 
Still, the mechanical thrombectomy 
procedure for acute stroke contributes
to a greater cost-efective outcome in 
terms of quality-adjusted life years
(QALY ) and reduces the cost of
long-term stroke care.2 The gain of
additional QALY translates into cost 
efectiveness which has been shown
across various countries and diferent 
types of health and economic sys-
tems across the world. Given the fact 
that clinical outcomes are strongly
dependent on time to recanalization 
(removing the blood clot), it is impor-
tant to examine the socioeconomic
disparity of geographic living distance
from thrombectomy capable stroke
centers as related to patient outcomes.
Currently, there is no literature com-
paring patient outcomes from throm-
bectomy to median income levels
and geographic living distance from 
accredited thrombectomy capable
stroke hospitals. In this study we
performed a comprehensive litera-
ture review to understand the cost
FIGURE: A. (left panel) Box and Whisker plot representing the difference in access 
to thrombectomy capable stroke centers (TCCs) within one hour of travel time in high,
medium, and low-income states (the y-axis shows the percentage of the population 
with one-hour access) The “x” within the box represents mean percent access, while 
the upper and lower limits represent the interquartile range  Note: the plot does not 
include Alaska  Since Alaska does not currently have a TCC and skewed the results 
B. (right panel)  Chart showing average median household income of states with high 
(>50%) rate of access to low (<50%) rate of one-hour access to endovascular care 
The Y-axis shows median household income in US dollars  Comparison of the median 
household income between states with high (>50%) and low (< 50%) one-hour access 
to endovascular stroke centers had an average median household income of $65009 
compared to $55683 (P < 0 001)  
efectiveness of mechanical throm-
bectomy in a global context. We
additionally estimated timely access
(less than one hour) to thrombectomy
capable stroke centers (TCCs) and
evaluate the relationship of access
with socio-economic status using US 
Census, median household income
and ambulance data. We further
demonstrate that timely access to
stroke care is imperative for optimal 
outcomes, and such access varies by
socioeconomic geography. To help
improve stroke outcomes nationally
and standardize access to care, more 
stroke centers could be developed
in geographical locations with lower 
median income. 
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Patient Data from Five Randomised
Trials.”Lancet 387.10029 (2016): 1723-31.
Print. 
2. Boudour S, et al. “A Systematic Review of 
Economic Evaluations on Stent-Retriever 
Th rombectomy for Acute Ischem ic
Stroke.” J Neurol 265.7 (2018): 1511-20.
Print. 
ABBREVIATIONS: 
Quality-adjusted life years (QALY),
t h rom b e c tomy ca pa ble  st roke 
centers (TCCs). United States of
America (USA), US Dollar(USD),
Solitaire With the Intention for
T h r o m b e c t o m y a s P r i m a r y  
Endovascular Treatment for Acute
Ischemic Stroke (SWIFT PRIME),
H i g h l y  Ef fe c t i ve Re p er f u sion 
Evaluated in Multiple Endovascular
Stroke Trials (HERMES), Mechanical
Embolus Remova l  i n C erebra l  
Ischemia (MERCI), Mechanical
thrombectomy after intravenous
alteplase versus alteplase alone after 
stroke (THRACE) 
TABLE: Table  Different studies showing Cost/QALY gained and data sources used 
Study Country 




treatment (Cost / 
QALY gained) 
Kunz et al , 2016 USA 
Hermes Collaboration,
meta-analysis 
(Goyal et al ) 
$3110 (2016) 
Shireman et al  USA SWIFT PRIME $4881 (USD 2015) 
Leppert et al , 2015 USA MR CLEAN $14 137 (USD 2012) 
Patil et al , 2009 USA MERCI study $12 120 (USD 2008) 
Kim et al , 2011 USA Multi-MERCI study $16 001 (USD 2009) 
Nguyen-Huynh et 
al , 2011 
USA Multi-MERCI study $9386 (USD 2009) 
Achit et al , 2017 France THRACE € 14,881 
Kabore et al , 2019 France SWIFT PRIME € 14,715 
Bouvy et al , 2013 Netherlands Expert panel opinion  € 1922 (Euros 2010) 






et al ) 
$11 651 (USD 2013) 

















































The Development of a Global Health Dermatologic 







George Washington University School of
Medicine and Health Sciences 
The annual incidence of malignant
melanoma in South Africa is amongst
the highest rates in the world at 4.76 
per 100,000 persons overall and up
to 19.2 per 100,000 in whites.1 While
South Africa has the highest number 
of medical schools in Sub-Saharan
Africa, surgical training for derma-
tologists has historically been limited.
The Global Health Dermatologic
Surgery (GHDS) Training Program
was developed to provide dermato-
logic surgery curriculum and training
to the registrars (residents), and con-
sultants (attending physicians), at the 
Nelson Mandela School of Medicine 
(NMSOM) in Durban, South Africa. 
We conducted a prospective quali-
tative study of the 15 total training
trips from 2014–19. The Institutional 
Review Board of the Nelson R.
Mandela School of Medicine at
the University of Kawzulu-Natal
approved this study. Patients were
screened for inclusion in this study by
local dermatologists and were sched-
uled for a procedure. Throughout the 
program, the following were recorded
in a REDCap database: tracking
of type of procedures, postopera-
tive complication rates (hematoma,
infection, dehiscence, pain, and sero-
sanguinous discharge), and patient
satisfaction surveys. Surgeons phoned
patients if they did not show up for
follow-up. In addition, consultant/ 
registrar surgical knowledge was
TABLE 1: Patient and Operative Characteristics at the Nelson Mandela Hospital,
2014–19 
Characteristics No. % 































Excisional Biopsy/Disc Excision 
ED&C 
Shave Excision 















































assessed by pre- and post-didactic
assessments. 
Seventeen volunteer surgeons
(four surgeons made multiple trips)
taught and super vised a total of
21 registrars and consultants over
the 15 trips between 2014–18. They
evaluated 362 patients and 387 pro-
cedures were performed. Of the 299 
patients who followed-up at one
week, 236 (78.93%) had no complica-
tions at all. 30 (10.03%) patients had 
reported infections of the surgical
site. Dehiscence of the surgical site



































TABLE 2: Complications and 
satisfaction survey results of patients 
who returned for one week follow up 
Outcome No. (%) 
Complications (n=299) 
No Complications 236 (78 93) 
Infection 30 (10 03) 
Other 15 (5 02) 
Dehiscence 12 (4 01) 
Hematoma 5 (1 67) 
Seroma 1 (0 33) 
Satisfaction survey result 
Site Appearance (n=259) 
“Very Satisfed” 123 (47 49) 
“Satisfed” 113 (43 63) 
“Indifferent,
No opinion” 
17 (6 56) 
“Not Satisfed” 6 (2 32) 
Site Feel (n=258) 
“Very Satisfed” 115 (44 57) 
“Satisfed” 124 (48 06) 
“Indifferent, No opinion” 12 (4 65) 
“Not Satisfed” 7 (2 71) 
was noted in 12 (4.01%) patients and 
hematomas reported in fve (1.67%)
patients. On a 1–4 scale, the mean
scores for both site appearance and
site feel was 3.37, indicating the most 
patients were “satisfed” to “very sat-
isfed” for their surgical site’s appear-
ance and feel at 1-week post operation.
Dermatologic surgery knowledge and
competencies were assessed using a
40-point test. Consultants and reg-
istrars significantly improved their
scores on the post-didactic assess-
ments; the diference in the posttest 
scores was 23.4 points (p = .003, 95% 
confdence interval 10.9, 35.9). 
Short term dermatologic medical 
ser vice trips, in which a visiting
dermatologist provides care to an
underserved group for a short period 
of time, provide poor long-term out-
comes and may not be cost-efective.2,3 
However, long-term educational pro-
grams with a focused clinical scope
may establish cost-efective long term
means of improving care.4 The GHDS
training program shares goals with
other international medical missions,
such as providing robust cultural
and educational exchange, but with
the primary goal of long term self-
fulflling sustainable surgical training,
thereby establishing the NMSOM as 
a training hub for sub-Saharan Africa
for future dermatologists. 
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Medical Cannabis Education Among 
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Calabria, MSII 
It was previously demonstrated that
health care professionals would like
additional education on medical can-
nabis.1 However, there has not yet
been a review of the status of medical
cannabis curriculum for allied health
care trainees worldwide. Given that
future health care workers will be
placed on the forefront of patient
care, they must be prepared to counsel
patients. This study was designed to
address this gap in knowledge.
Methods: A search syntax was
generated and the PubMed, ERIC,
CINAHL, and Web of Science data-
bases were searched for relevant
articles. A gray literature search of
Google Scholar, MedEd, Medline,
and the Proquest Dissertations and
Theses section was
also performed. All
medical and allied health students
are not properly educated and knowl-
edgeable on this emerging field of
clinical care. The findings suggest
that the implementation of compe-
tency-based curricula on medical can-
nabis is essential for allied health care
titles and abstracts While the medical cannabis landscape is devel-
w e r e  s c r e e n e d  .  
S e l e c te d  a r t ic l e s  oping, medical and allied health students are 
were subsequently
screened using pre- not properly educated and knowledgeable on
determined inclu-
sion and exclusion this emerging feld of clinical care. 
criteria.
Re sul t s: A l l ied 
health care trainees lacked suffi-
cient knowledge about medical can-
nabis and did not feel prepared to
counsel patients on this subject.
They expressed a growing interest in
medical cannabis and would like more
standardized education on the topic.
Faculty and deans at various institu-
tions agreed on the need to educate
students on the subject and aimed
to implement courses on medical
cannabis or expand their existing
curricula.
Conclusions: While the medical
cannabis landscape is developing,
trainees to have the appropriate level
of knowledge to counsel and educate
their patients.
REFERENCES 
1. Gardiner KM, Singleton JA, Sheridan
J, Kyle GJ, Nissen LM. Health profes-
sional beliefs, knowledge, and concerns
surrounding medicinal cannabis — A
systematic review. PloS ONE. 2019;14(5). 
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Review of Homeless Health Care Research 
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Homelessness presents significant
barriers to health care and is associ-
ated with increased hospitalizations.1 
Interventions aimed at improving
care transitions and facilitating access
to stable housing are key to reducing 
hospital visits and readmissions.2 The
state of homeless health care and its 
associated costs are important areas 
of public health research as these
investigations provide essential data 
needed to motivate targeted inter-
ventions such as medical respite
programs.2 Here we present a sys-
tematic review of investigations into 
the state of homeless health care,
focusing on risk factors for hospital
readmission, demographics, and the
most commonly used study designs.
All together, we aim to more clearly 
defne a roadmap for future research. 
Methods: The literature search
FIGURE 1: An overview of the results and characteristics of the literature review 
performed  
was carried out using standard-
ized PRISMA criteria, using the
PubMed database and the MeSh
terms: “(Homeless Persons) AND
(Readmission).” The references of
retrieved articles were reviewed for
identifcation of additional relevant
studies. Primary inclusion criteria
were defined as the article investi-
gating either homeless readmission
rate, causes of homeless readmission, 
or risk factors for homeless readmis-
sion. Abstracts not meeting these
criteria were excluded. Article data
was then extracted, aggregated, and
analyzed. Statistical and numerical
analysis was performed in GraphPad 
v8 statistical software package. 
Results: The literature search
returned a total of 81 articles. As shown
in Figure 1.A, 33 articles were excluded.
Figure 1.B shows the majority of
articles (52%, n=25) were a retrospec-
tive cohort study. Other study designs
Continued on p. 28 
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w/ Medicaid Claims Data 
Interventions: 
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Control Group Trial 
Continued fom p. 27 
included prospective cohort (18.7%,
n=9), randomized control trial (4.2%,
n=2), case control (4.2%, n=2), case
series (2.1%, n=1), and hybrid/combi-
natorial design (18.7%, n=9). A total
of 1,748,550 patients experiencing
homelessness were described amongst
the 48 articles. Figure 1.C summarizes
demographic data collected in this
study. Approximately 60% of that
cohort identifed as male with a mean
age of 39 years old. Race distribution
among the cohort was 38% Caucasian,
40% African American, 5% Asian, 4%
Native American, and 28% Hispanic.
Twenty broad themes of risk factors
[Figure 1.D] were identifed for patient
readmission, with the most commonly
mentioned risk factors being chronic
neuropsychiatric disease (mentioned
in 26% of 39 articles that analyzed
risk factors), illicit drug abuse disorder
(18%), and alcohol abuse disorder
(10%).
Discussion: Retrospective designs 
were by far the most commonly used. 
A 2017 systematic review tabulated
the ways in which numerous retro-
spective studies identifed homeless
patients by information found in
patient charts.3 Identifcation criteria
for homeless patients was widely het-
erogenous between studies and the
lack of reliable standardization was
noted to be a significant drawback
towards data interpretation across
multiple retrospective investigations.
Our fnding that retrospective designs
are most commonly used in the study 
of homeless medicine highlights the 
importance of implementing stan-
dardized homeless screening tools
in the hospital setting [Figure 2].
Fundamental to studying homeless
FIGURE 2:Study designs in homeless medicine and associated interventions  
health care is the ability to reliably
identify homeless patients.4 
Our review also revealed a new
methodology for investigating home-
less health care.5 Racine et al. col-
lected homeless person Medicaid
identifcation numbers from a non-
proft database and matched the IDs 
to the Massachusetts Medicaid claims
database. This revealed detailed
person-level homeless health care uti-
lization information such as city-wide
hospitalizations, ED visits, expen-
ditures, and diagnoses all without
relying on patient chart information. 
Not all cities have access to similar
databases required to replicate these
analyses, but Homeless Management 
Information Systems, which are
found more commonly, may prove to 
be a useful tool for designing similar 
database-matching investigations.
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Characterizing Injury Patterns of Casualties in Bombings  




Randy S  Bell,1,2 
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* Disclaimer: The views expressed in 
this article are those of the authors 
and do not refect the offcial policy 
of the Department of Army/Navy/Air 
Force, Department of Defense, or the
United States Government. 
Introduction: Explosions and bomb-
ings remain real threats that have the 
capacity to quickly create thousands 
of casualties with devastating injuries
(see Figure 1 a,b). Because of this, the 
medical community needs to remain 
ready to respond to these high-stress 
... [T]he fatality rates from neurological
injury are approximately equal; therefore,
the data suggest injuries sustained in the
setting of helmet protection are more likely 
to be survivable. 
events. To date, few articles have
summarized key details of blast injury
profles in terrorist bombings globally,
and no studies have analyzed the dif-
ference in blast injury profles between
Military and Civilian populations.
Thus, the primary aim of this study1 
FIGURE 1: Temporal (A) and geographic (B) distribution of bombings related to 
terrorism from 2015–18  
was to perform a literature review and
meta-analysis of all articles reporting 
on blast injury trauma with the ulti-
mate goal of ascertaining diferences 





tion a nd education 
in medical facilities
worldwide. 
Methods:  The l it-
erat u re sea rch wa s 
designed and executed
(per PRISMA guide-
l i n e s)  t o  c o m p a r e  
blast injury patterns
between Military and Civilian casual-
ties following terrorist bombing. The 
search was performed using selected 
MeSH search terms. Injury pattern
data was extracted and stratifed into 
Abbreviated Injury Scale (AIS) body 
region numerical descriptors for the
head/neck (1,3), thorax (4), abdomen
(5), and extremities (7,8). Data means 
were then calculated for each AIS-
defined region and then compared
between articles describing Military 
populations versus those describing
Civilian populations. Statistical
analysis was performed in GraphPad 
Prism v8 statistical software package 
(San Diego, California). Data sets
were initially scrutinized for nor-
mality, then assessed for statistically 
significant differences (defined as
alpha < 0.05) using Welch’s t-test of
unequal variance. Error within the
data sets were reported as a 95%
Confdence Interval (CI). 
Results: The literature search
revealed a total of 806 articles (342
Military, 464 Civilian), with 28 (10
Military, 18 Civilian) meeting all
inclusion criteria. A total of 33,387
unique injuries were reported (n=18,711
Continued on p. 30 
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Continued fom p. 29 
Military, n=14,676 Civilian) in these 
articles. Figure 1 shows that there are 
several diferences in injury patterns. 
In both populations, AIS regions 7,8 
were most afected by bombings, fol-
lowed by AIS 1,3, AIS 5, then AIS 4. 
In addition, there was a signifcant
diference between injuries reported
in AIS regions 1+3 reported between 
the Military and Civilian popula-
tions (p=0.00632). There were also
marginally lower reports of thora-
coabdominal injuries in the Military 
population compared to Civilians,
but outliers in both data sets make
statistical conclusions difcult. There
were no significant differences in
victim age, reports of limb injuries, or
proportion of instantaneous fatalities
in either population. 
Conclusions: Given that Military
members typically wear protective
body armor and ballistic helmets
when exposed to a blast, it was unex-
pected to see a higher number of head
and neck injuries.  Even though there 
are increased reports of head and
FIGURE 2: Blast injury patterns and differences between Military and Civilian 
personnel  
neck injuries, the fatality rates from 
neurological injury are approximately
equal; therefore, the data suggest
injuries sustained in the setting of
helmet protection are more likely
to be sur vivable. Ultimately this
implies that in a given blast MCI,
the Militar y Treatment Facility
receiving casualties might actually see
a higher number of patients with blast
neurotrauma compared to Civilian
hospitals. Though this hypothesis
requires further investigation, this
fnding emphasizes the importance 
of neurotrauma stabilization and the 
importance of intimate integration 
of the neurosurgical service in the
preparation and response phases of
mass casualty scenarios related to
terrorism bombings. 
REFERENCES: 
1. Tovar MA, Bell RS, Neal CJ. Epidemiology 
of Blast Neurotrauma: A Meta-Analysis
of Blast Injury Patterns in the Military
and Civilian Populations. World Neuro-
surgery, 2020. https://doi.org/10.1016/j. 
wneu.2020.11.093. 



























































































■ DRC R {n-25) DROTC (n-50) D NROTC (n"-88), 
Consumer Attitudes and Behaviors on  








Kamaria Nelson, MD; Andrew Sparks, MS
ADVISOR: Adam Friedman, MD1 
1 Department of Dermatology, The George
Washington University School of Medicine
and Health Sciences 
Access to medical cannabis products
(MCPs) has rapidly increased due
to changing regulatory landscapes.1 
However, literature on consumer
behaviors and attitudes with regards to
dermatologic use is limited, and there-
fore we sought to address this gap.2 
Methods: A survey was emailed via
SurveyMonkey’s platform to users 18
and older of their rewards panel asking
about usage patterns and beliefs
regarding MCP use to treat dermato-
logic conditions.
Results: 504 adults completed our
survey (92.1% response rate) with a
relatively consistent distribution of
age and gender. 17.6% of respondents
used an over-the-counter (OTC) can-
nabis product without dermatologist
recommendation (NROTC: non-rec-
ommended, over-the-counter) to treat
a skin condition. The most common
indications were acne (28.4%), pso-
riasis (26.1%) and atopic dermatitis
(22.7%) (Figure) and the most common
route of administration (ROA) was
topical (64.7%). Of those who had seen
a dermatologist (66.3%), 15.3% used
an OTC product per their derma-
tologist’s recommendation (DROTC:
dermatologist recommended, over-
the-counter), most commonly for
FIGURE: Self-reported reasons for using cannabis products  Respondents who 
indicated they had used a DRCR (n=25), DROTC (n=50), or NROTC (n=88) cannabis 
product for a dermatologic indication were asked to indicate from a list of choices what 
indication they had used the product for  Respondents in the DRCR and DROTC groups 
were only given the option to answer only if they had seen a dermatologist, were 
recommended these products by the dermatologist, and they respondent subsequently 
used the product Values are reported as percentage of respondents who selected an 
answer  Respondents were allowed to select more than one option  
psoriasis (32%), rosacea (30%), and
acne (30%) (Figure) and the most
common ROA was topical (62.5%).
7.8% of those who had seen a derma-
tologist used an MCP which required
a Department of Health-approved
card per their dermatologist’s recom-
mendation (DRCR: dermatologist
recommended, card requiring), most
commonly for acne (68%), psoriasis
(28%), and rosacea (28%) (Figure) and
the most common ROA was ingestion
(50%) per their dermatologist’s rec-
ommendations. 11.8% of respondents
were not comfortable seeing a derma-
tologist who recommended MCPs and
6.4% of respondents disapproved the
use of cannabinoids for dermatologic
indications.
Conclusion: This survey shows that
consumers use cannabis products for
numerous dermatologic conditions.
Inf lammator y disorders such as
acne, psoriasis, atopic dermatitis, and
rosacea were among some of the con-
ditions being most frequently treated
by cannabis products. It is important
to note that current literature on the
subject is limited, and the benefits
and risks of use are not well under-
stood. Physicians should be aware of
common barriers to initiating treat-
ment with MCPs, such as skepticism
and poor understanding, as well as cost
and legality issues. Given the interest
in medical cannabis for dermatologic
use as shown by this study, it is impor-
tant for dermatologists to stay up to
date with the scientifc and legal land-
scapes in order to best serve patient
needs. It is important to understand
and inform patients who may seek out
Continued on p. 32 
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Reasons for Initiating a Telehealth Appointment 
Continued fom p. 31 patients who are interested in alterna- www.ncsl.org/research/health/state-
medical-marijuana-laws.aspx.) tive therapies.
cannabis products that recognized, 2. Robinson E, Murphy E, Friedman A.REFERENCES Knowledge, Attitudes, and Perceptionsevidence-based treatments currently
of Cannabinoids in the Dermatolog y1. State Medical Marijuana Laws. Published remain the standard of care, though Community. J Drugs Dermatol. 2018;July 2, 2019. (Accessed July 18, 2019, http:// 
MCPs may be a suitable option for 17(12):1273-1278.
Patient Experiences with Teledermatology During  
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The COVID-19 pandemic has drasti- FIGURE: Pie chart indicating reasons for patients’ telehealth appointment  N=168 
cally changed the practice of derma- Respondents were only allowed to select one answer from a dropdown menu  
tology as social distancing guidelines
have led to a shift from in-ofce care to were because of time efciency (81.1%), reported drawbacks include patients
virtual telehealth (teledermatology).1 not requiring transportation (74.2%), feeling like they did not receive an
We aimed to determine patient sat- and maintaining social distancing adequate examination or did not have
isfaction, perceived barriers, as well (73.6%). The most common reasons any physician touch though these were
as indications for teledermatology respondents did not like telehealth still reported in a minority of patients.
appointments during the COVID-19 were due to lack of physical touch Overall, the convenience and efcacy
pandemic. (26.8%) and feeling they received an of telehealth as well as its ability to
Methods: A survey was sent out inadequate assessment (15.7%). Very maintain separation while social dis-
via Sur veyMonkey’s online plat- few patients reported that they were tancing recommendations are in place
form to the George Washington unlikely to undertake another tele- make it an efective way for derma-
University Medical Faculty Associates’ health visit (9.94%) or recommend a tologists to continue to provide quality
Department of Dermatology patients telehealth visit to others (6.92%). and safe care during the pandemic as
who were 18 years and older and Conclusion: As the COVID-19 well as during potential future public
attended telehealth appointments pandemic continues to afect millions health crises.
during the COVID-19 pandemic. of patients who require dermatology
REFERENCES Results: Out of 894 invitations care, telehealth proves to be an efec-
sent, 168 patients completed our tive and useful modality to bring care 1. Gough, PJ. UPMC sees “phenomenal
increase” in telemedicine use in COVID-19survey (18.8% response rate). The to patients during this public health
crisis. Pittsburgh Business Times. Pub-most common reasons for making a emergency. The majority of patients lished March 28, 2020. (Accessed June 3, telehealth appointment were for a new who had telehealth encounters with 2020. www.bizjournals.com/pittsburgh/
rash (11.6%), eczema (9.8%), and psori- our dermatology department found news/2020/03/28/upmc-sees-phenomenal-
asis (9.1%) (Figure). The most common a telehealth visit to be an adequate increase-in-telemedicine-use.html) 
reasons respondents liked telehealth substitute for an in-person visit. Major
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Predicting Deletion of Chromosomal Arms 1p/19q in  
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Several studies have linked co-dele-
tion of chromosome arms 1p/19q in
low-grade gliomas (LGG) with posi-
tive response to treatment and longer 
progression-free survival. Hence,
predicting 1p/19q status is crucial for 
efective treatment planning of LGG.
In this study, we predict the 1p/19q
status from MR images using convolu-
tional neural networks (CNN), which
could be a non-invasive alternative to 
surgical biopsy and histopathological
analysis. Our method consists of three
main steps: image registration, tumor
segmentation, and classif ication
Continued on p. 34 
FIGURE 1: An example of low-grade glioma with and without 1p/19q 
codeletion. Images a and b show T2 and post contrast T1 for non-deleted 
1p/19q. Images c and d show T2 and post contrast T1 for codeletied 1p/19q. 
FIGURE 2: A fowchart of the multi-scale CNN archetecture  Blue box is the input image Yellow boxes are convolutional layers  Green 
boxes are rectifed linear unitys (RELU), activations  Red Boxes are max pooling layers  Purple boxes are fully connected layers, plus a 
softmax binary classifer  Cyan circle shows the output label 
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Continued fom p. 33 
of 1p/19q status using CNN. We
included a total of 159 LGG with three
image slices each who had biopsy-
proven 1p/19q status (57 non-deleted 
and 102 co-deleted) and preoperative 
postcontrast-T1 (T1C) and T2 images. 
We divided our data into training,
validation, and test sets. The training 
data was balanced for equal class prob-
ability and was then augmented with 
iterations of random translational
shift, rotation, and horizontal and
vertical fips to increase the size of
the training set. We shufed and aug-
mented the training data to counter 
overfitting in each epoch. Finally,
we evaluated several confgurations 
of a multi-scale CNN architecture
until training and validation accura-
cies became consistent. The results
of the best performing confguration 
on the unseen test set were 93.3%
(sensitivity), 82.22% (specifcity), and 
87.7% (accuracy). Multi-scale CNN
with their self-learning capability pro-
vides promising results for predicting 
1p/19q status non-invasively based
on T1C and T2 images. Predicting
1p/19q status non-invasively from MR
images would allow selecting efective
treatment strategies for LGG patients
without the need for surgical biopsy.1 
REFERENCES: 
1. Akkus Z, Ali I, Sedlář J, Agrawal JP,
Parney IF, Giannini C, Erickson BJ.
Predicting Deletion of Chromosomal
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MR Images Using Machine Intelligence. 
J Digit Imaging. 2017 Aug;30(4):469-476. 
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28600641; PMCID: PMC5537096. 
Malignant Pineal Parenchymal Tumors in Adults:  









ADVISORS: Ashkan Monfared,1 Richard D 
Murray1,2
1 Department of Neurosurgery, The George
Washington University School of Medicine
and Health Sciences
2 Department of Neurosurgery, Virginia
Hospital Center 
In the absence of randomized trials
for adult pineal parenchymal tumors 
(PPT), we use a national database to 
evaluate treatment trends and the
survival impact of surgery, radiation, 
and chemotherapy. 
Methods: The National Cancer
Database was queried for adult 
patients with histologically confrmed
PPT diagnosed from 2004 to 2016.
Univariate and multivariate Cox
regressions were used to evaluate
the prognostic impact of covariates.
K a pl a n -Meier  s u r v i v a l  c u r ves  
FIGURE 1: Stacked Bar Graph of Treatment Trends for PB and PPTID  PB is most 
commonly treated with surgery and adjuvant chemoradiation  PPTID is most commonly 
treated with surgery alone or with surgery and adjuvant radiation  
were generated for comparative
subanalyses. 
Results: A total of 202 patients
met inclusion criteria. A plurality
of pineoblastoma ( PB) patients 
were treated with trimodal therapy
(43.6%, 24/55) ( Fig ure 1). Pinea l
parenchymal tumor of intermediate
differentiation (PPTID) patients
were most commonly treated with
either surgery alone (35.1%, 47/134)
or with surgery and radiation (32.8%,
44/134) (Figure 1). Factors associated
with improved overall survival on
mu ltiva riable a na lysis included 
younger patient age, female sex, lower
comorbidity score, receipt of surgery,
and receipt of radiation (each p < .05).
Receipt of chemotherapy was not
associated with survival. Subanalyses
revealed that the efect of radiation
on survival was most prominent in
PB patients and in PPTID patients
w ho h ad not recei ved su rger y 
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(Figure  2). No survival benefit of
adjuvant radiation was demonstrated 
in surgically treated PPTID patients
(Figure 2). 
Conclusions: Currently, there is a
paucity of data regarding treatment
outcomes for adult PPT tumors, and
this is the largest study to date.1,2 
While radiotherapy and surgery were
found to increase survival in all PPT
patients, there was no survival beneft
of adjuvant radiation in surgically
treated PP TID. T h is su g gests 
overtreatment of many PPTID adult
patients with radiotherapy. 
REFERENCES: 
1.  S e l v a n a t h a n  S K ,  H a m m o u c h e  S ,  
Smethurst W, Salminen HJ, Jenkinson
MD. Outcome and prognostic features in 
FIGURE 2: Kaplan-Meier Survival 
Curves Of Adult Patients With PPTID 
A) Surgery is associated with improved 
survival in adults with PPTID  B) PPTID 
adults that have received surgery do not 
experience improved survival with adjuvant 
radiation  C) PPTID adults receiving no 
operation tend to experience improved 
survival with added radiation  
adult pineoblastomas: Analysis of cases
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Impact of Varian Histology on Occult Nodal Metastasis after 
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: 








1 The George Washington University School
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2 The Brody School of Medicine at East
Carolina University 
Variant histology accounts for 30%
of bladder urothelia l carcinoma
cases. Variant histology is associated
with a higher incidence of locally
advanced disease and occult regional
lymph node metastasis.1 Neoadjuvant
chemotherapy (NAC) is the gold-
standard treatment for resectable
cT2-4 disease as it achieves pathologic
complete response in select patients
at the time of radical cystectomy
(RC). Post-hoc analysis of a landmark
randomized trial has demonstrated
preserved chemosensitivity and even
pT0 status in the setting of variant his-
tology. While there is much interest
in the role of bladder preservation
for such patients, the observation
of pT0N+ pathology in patients who
undergo subsequent RC has prompted
concerns about this approach.2 The 
aim of this study is to analyze how
variant histology impacts pathologic
downstaging after NAC.
A retrospective cohort analysis of
5,335 cT2-4N0M0 patients who under-
went NAC and RC between 2004
and 2016 was performed using the
National Cancer Database (NCDB). 
These patients were stratified by
histological type into pure urothelial
cell carcinoma (UCC) and variant
groups (i.e. neuroendocrine, micro-
papil lar y, squamous, etc.) using
the WHO ICD-O classification.
FIGURE: Kaplan-Meier Curve of Pure UCC and Variant Histology Types  
of 48.8% compa red to 38.5% in 
the variant group (p<0.001). After
adjusting, UCC was associated with
significantly decreased mortality
hazard relative to variant histology
The rate of pathologic
downstaging to ≤pT1 
was analyzed, along with
concomitant persistent 
pN+ status. Overall sur-





fied by histology type.
Multivariable models were adjusted
for confounding demographic and
clinicopathologic variables. 
Of the cases, 7.9% were variant
histolog y while 92.1% were pure
UCC.  Pure UCC was associated
with signifcantly better unadjusted
survival with a 5-year survival rate
Our study showed that the propensity for 
distant spread contributed to signifcantly
worse survival outcomes in the variant
histology group. 
(a HR= 0.75; p<0.001). UCC had 
lower adjusted odds of being pN+
(aOR=0.60, p<0.001), specifically
pN2 (aOR=0.57) and pN3 (aOR=0.40).
Node-positive variant histolog y
patients demonstrated higher node
positive count compared to pure UCC
(median 3 vs 2 nodes, p<0.001).





















     






Outcome Mixed Histology PureUCC Adjusted Odds Ratio p-value 
(n=419) (n=4916) (95% en 
Path Node Status 
0 311 (74.2%) 4030 {82.0%) Reference -
l 36 (8.6%) 366 (7.5%) 0.75 (0.51 - l.l l) 0.146 
2 55 (13.l %) 426 (8.7%) 0.57 (0.41 - 0.79) <0.001 
3 17(4.1%) 94 (1.9%) 0.40 (0.23 - 0.70) 0.001 
Path Node+ 108 (25.8%) 886 (18.0%) 0.60 (0.47 - 0.77) <0.001 
Downstage to pT0 I JO (26.3%) 1269 (25.8%) 0.99 (0.75 - 1.31) 0.948 
Complete 104 (24.8%) 1235 (25.1%) 1.04 (0. 78 - 1.38) 0.815 
Downstage to 
pT0N0 
Partial downstage to 45 (10.7%) 689 (14.0%) 1.25 (0.89 - 1.75) 0.192 
12Ii~. 12Ia p TI 
Any PI.downstage 155 (37.0%) 1958 (39.8%) 1.13 (0.89 - 1.44) 0.317 
Downstage pT0Nl-3 6 (1.4%) 34 (0.7%) 0.53 (0.20 - 1.37) 0.190 
O u r st ud y showed t h at t he 
prop en sit y  f or  d i st a nt  spr e a d 
contributed to significantly worse
sur vival outcomes in the variant
histology group. Patients with variant
histology were more likely to harbor 
occult regional lymph node metastasis
in the setting of intravesical pathologic
complete response (pT0). Although
micropapillary histology was more
likely to be downstaged to pT0,
the increased likelihood of residual
nodal disease reinforces the role of
surgical consolidation after NAC for 
these patients. On the other hand,
neuroendocrine histology may allow
for successful bladder preservation
a f te r  c h e m ot h e r a p y  g i v e n  it s  
higher downstaging to pT0N0. RC
with thorough pelvic lymph node
dissection remains the gold-standard 
for surgical consolidation after NAC, 
especially in cases of variant histology. 
TABLE:
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node involvement in bladder cancer:
implications for definitive radiation.
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Evaluation of Selective HDAC6 Inhibition as a  
Potentiator of Antigen-Targeted Immunotherapy in  







Biochemistry and Molecular Medicine,
The George Washington University School of
Medicine and Health Sciences 
Patients with aggressive difuse large 
B-cell lymphoma (DLBCL) who fail
initial combination therapy, may
undergo second-line treatment with
curative intent; however, treatment
involves high-dose chemotherapy and
autologous stem cell transplantation,
which is reserved only for eligible
candidates.1 One-third of candidates
will proceed with high-dose therapy
with durable remission rates limited
to approximately 25%.1 
Clearly, there exists a population 
of patients in need of new treatments. 
Hope may be found in anti-CD19
chimeric antigen receptor (CAR)
T-cell therapy, which has garnered
wide success in the treatment of
pre-B-cell acute lymphoblastic leu-
kemia (ALL).2,3 Although CAR T-cell
therapy has not had the same level of
success in DLBCL, results remain
encouraging and demonstrate a need
for further research. Additionally,
clinical studies of bispecific anti-
CD19xCD3 or a nti- CD20xCD3
monoclonal antibodies have shown
similar promise.4 
Despite the excitement sur-
rounding antigen-targeted immuno-
therapies, these novel treatments face
critical obstacles. Patients receiving
CAR T-cell therapy or bispecific
FIGURE 1:
monoclonal antibodies might only
beneft from brief remissions or may 
never enter remission at all. 2,3 Similar 
to existing treatments, CAR T-cell
therapy is challenged by resistance
and failure of long-term disease
remission.2,3 
One reason may be antigen loss.
Several studies have demonstrated the
generation of escape variants lacking 
the targeted CD19 or CD20 antigens 
when under the selective pressure of 
immunotherapy. A theorized mecha-
nism for this is interrupted protein
translocation, supported by observa-
tions of CD20 trafcking disruption 
in rituximab-resistant B-cell cancers.4 
Histone deacetylase 6 inhibitors
(HDAC6i) have been well charac-
terized as modulators of protein































      
 
 





















~ ' !i 
l ! " 
1! 
'P d 
;r; I 0-s 
...... 
RaJIUNT 
Raj I4RH IL-4 + NA 
Rajl4RHNA 
Raj I4RH IL-4 
Rajl4RH UNT 
24-hour Raji 4RH (Res.) Median C020 
Fluorescence Intensity 
(SO ng/ml ll-4) 





5.0µMNA r= 2.SµMNA ■ l.OµMNA 
■ Unlfnted ··-i·: ... 
Comp•Al'C•A 
C 
NA [c.on.J (µM) Untreated 
1 hour I 
6hours 




I ~-i- I I I I I-
lajl_,....IUNT "41-f1111Llll4 .. - ...... INA ... •-:--I"-'• -.-






I I I I : ., ,_. 
" 
,_. 
Not1o1t;Hl~I A (11M) 




Neirt .. J.!t,,.1iM1 
1.0 ,_, ,_, 10.0 
11042 11292 
10936 1125 
trafcking and have been shown to
upregulate the expression of CD20 on
B-cell tumor lines.4,5 Achieving a sim-
ilar efect with CD19 expression may 
ofer a new avenue for potentiating
anti-CD19 CAR T-cell platforms,
particularly because immunotherapy 
studies have shown that only a small 
diminution of surface antigen may be 
sufcient for treatment failure.3 
Through our studies, we investi-
gated the efect of HDAC6i on sur-
face expression of CD19 and CD20
in rituximab-resistant (CD20-low)
Raji4RH cells. Raji4RH cells were
treated with either 50 ng/mL IL-4,
5µM of the HDAC6i, Nexturastat
A (NextA), or a combination thereof 
for 48 hours. Untreated Raji4RH cells
and untreated Raji cells (CD20-high) 
were used as controls. HDAC6i in
combination with IL-4 increased
CD20 expression in rituximab-resis-
tant Raji4RH cells (Figure 1a). Later, 
at concentrations of 10µM, HDAC6i 
achieve a 2-fold increase in CD20 sur-
face expression as reported by median
fuorescence intensity compared to
the untreated control (Figure 1b).
Next, rituximab-resistant Raji4RH
cells were treated with 50 ng/mL IL-4
and increasing doses of NextA for 24 
hours. (Figure 2). When examining
mean CD19 fuorescence, we observed
an increase, although modest, in
CD19 surface expression at 1-hour and
6-hours post-treatment. 
O u r  r e s u lt s  e s t a b l i s h  t h a t  
HDAC6is can increase CD20 expres-
sion in CD20-low B-cells and suggest 
a strong potential for HDAC6i to
function as a positive modulator of
CD20 expression in the setting of
resistant disease. Additionally, our
studies suggest that there exists an
interaction between HDAC6 func-
tion and CD19 surface expression.
These results are promising as even
slight changes in surface expression of
antigen targets can greatly infuence 
immunotherapy response. However, 
further optimization of treatment
FIGURE 3: 
FIGURE 2: 
dosing and cytokine combination is
necessary, warranting the need for
future studies. 
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or pT(any)Nl-3 bladder adenocarcinoma 
from NCDB 2010-2016 (n=330) 
Adjuvant chemotherapy No adjuvant chemotherapy 
(n=79) (n=251) 
Comparison #1: Radical (n=56) vs. 
Partial Cystectomy (n=23) (RC vs PC) 
Comparison #2: Urachal (n=l0) vs. 
Non-Urachal Subtype (n=69) 
The Impact of Adjuvant Chemotherapy on Oncologic Outcomes of
Patients with Locally Advanced Bladder Adenocarcinoma:  
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Adenocarcinoma of the bladder is an
especially rare histological subtype
of bladder neoplasms, accounting for
approximately 0.5-2% of diagnoses
in the United States.1 These tumors
can be further classified based on
origin from the urachus, an embryo-
logic structure that functions to
connect the developing bladder to
the allantois. In up to one-third of
individuals, remnants of these devel-
opmental tissues may persist and serve
as a potential location for malignancy.
Importantly, there is little consistent
evidence regarding the treatment
of both non-urachal and urachal
adenocarcinomas.2 Although radical 
cystectomy (RC) is often considered
the standard of care for both locally
advanced urachal and non-urachal
adenocarcinomas, there is a paucity
of data providing conclusive guidance
regarding any additional management
options that may be of beneft in such
an uncommon histological bladder
neoplasm.3 Specifcally, the relatively
poor prognosis associated with locally
advanced bladder adenocarcinoma
necessitates investigation of the utility
of adjuvant chemotherapy (AC) and
FIGURE:Methofological breakdowns  
risk stratifcation of those who would
beneft from such systemic therapy.
This study seeks to evaluate the onco-
logic and surgical outcomes of those
with locally advanced disease treated
with and without AC.
Methods: A retrospective cohort
analysis was performed using the
National Cancer Database from 2006
to 2016. Patients with non-metastatic
locally advanced pT3-4 or pT(any)N1-3
primary bladder adenocarcinoma who
received AC only or did not receive
AC after radical or partial cystectomy
(PC) were included. The AC cohort
was further sub-stratifed by surgery
type (PC versus RC) and disease
origin (urachal versus non-urachal
subtypes) (Figure). Survival, oncologic,
and surgical outcomes were compared
between cohorts. 
Results: Inclusion criteria identifed
79 AC patients and 251 no AC patients.
Of the 79 patients who received AC,
23 had PC procedure, 56 had RC pro-
cedure, 10 had urachal origin and 69
had non-urachal origin. Receipt of AC
was signifcantly higher in RC rela-
tive to PC (27.6% vs 18.1%; p = 0.049).
Urachal vs. non-urachal subtype did
not impact receipt of AC (25.3% vs
17.5%; p = 0.214), but urachal subtype
was associated with improved overall
survival compared to non-urachal
(47% vs 18%; HR = 0.37; p = 0.04).
Although receipt of AC was signif-
cantly associated with higher odds of
positive margins (46% vs 23%; odds
ratio = 2.85; p < 0.01), no diference in
overall survival was detected between
the AC and no AC cohorts (23% vs
19%; hazards ratio [HR] = 0.98; p =
0.91). Of note, independent of AC, PC
was associated with improved survival
compared to RC (51% vs 12%; HR =
0.25; p < 0.01).
Conclusions: There is no detected 
sur viva l benef it to the use of a 
41 CLINICAL RESEARCH | ONCOLOGY
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non-standardized AC regimen in
locally advanced bladder adenocarci-
noma. Within the AC treated popula-
tion, survival outcomes suggest that 
urachal subtype may confer survival
advantage and that those patients
selected for PC tend to have improved
sur viva l. A lthough employing a
national dataset, statistical power was
limited given the rarity of this disease.
Further investigation is warranted on
a larger scale in order to assess the
impact of AC regimen, aford proper
patient selection, and enhance risk
stratifcation for oncologic outcomes.
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Comparison of Perioperative Characteristics and Outcomes 
for Minimally Invasive vs Open Retroperitoneal Lymph Node 
Dissection for the Treatment of Testicular Cancer: A NSQIP Analysis 
is an established post-orchiectomy RPLND. As such, the present study Multivariable logistic regression
treatment option for men with clinical queries the National Surgical Quality and multivariable generalized linear
stage I and IIA/B non-seminomatous Improvement Program (NSQIP) models were used to analyze indepen-
germ cell tumors (NSGCTs).1,2 Open database to assess 30-day periopera- dent associations between treatment
RPLND is currently considered tive outcomes and characteristics for approach and perioperative outcomes.
the gold standard approach for low MIS vs open RPLND along with Trends over time were analyzed by
stage NSGCT; however, it is a major trends over time. way of Spearman’s rank correlation
abdominal procedure associated with The NSQIP database (2005–18) coefcient analysis, ρ. All statistical
signifcant morbidity and prolonged was queried for patients with non- analysis was performed using SAS
hospital stays.3,4 A minimally inva- disseminated testicular cancer ± version 9.4 (SAS Institute Inc., Cary, 
sive surgical (MIS) approach seeks retroperitoneal lymph node involve- NC) with a two-sided p-value < 0.05 
to aford patients similar oncologic ment. Patients with distant metas- considered statistically signifcant.
outcomes with decreased morbidity. tasis, a history of chemotherapy, or Inclusion criteria identifed 646
Outcomes in robotic and laparo- a history of radiation therapy were patients; 337 (52.2%) with MIS treat-
scopic RPLND for the management excluded. Chi-square, Fisher’s exact ment and 309 (47.8%) with open
of NSGCT have been studied in test, independent samples t-test, and treatment. Compared to open, MIS
recent case series, however limited Mann-Whitney U test were used to RPLND was signifcantly associated 
data currently exists directly com- identify unadjusted associations and 
paring outcomes in MIS versus open potential confounding covariates. Continued on p. 42 
FIGURE: RPLND Procedures by Year 
Testicular cancer is the most common
solid tumor in young men ages 20 to 
34 years old.1 Primary retroperitoneal
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or β (SE) 
Multivariable
p-value 
Superfcial SSI 4 (1 3%) 2 (0 6%) 0 433 
0 87 
(0 12 – 6 34) 
0 89 
Bleeding Transfusion 23 (7 4%) 13 (3 9%) 0 047 
1 19 
(0 54 – 2 62) 
0 672 
Mortality — 3 (0 9%) 0 25 NE — 
Return to OR 5 (1 6%) 9 (2 7%) 0 359 
1 07 
(0 28 – 4 12) 
0 927 
Acute Care Stay >30 day — 1 (0 3%) 0 999 NE — 
Reoperation 4 (1 3%) 6 (1 8%) 0 754 
0 96
(0 19 – 4 69) 
0 955 
Readmission 18 (5 8%) 20 (5 9%) 0 953 
0 96 
(0 44 – 2 14) 
0 928 
C  Diffcile 1 (0 3%) 3 (0 9%) 0 625 NE — 
Operative Time Mean ± SD 274 ± 124 147 ± 118 <0 001 -35 (9) <0 001 
Length of Hospital Stay
Median (Q1, Q3) 
4 (3, 6) 1 (0, 5) <0 001 -0 41 (0 07)* <0 001 
aOR=adjusted odds ratio for MIS vs open; CI=confdence interval; β=parameter estimate; SE=standard error; OR=operating room; 
SSI=surgical site infection; NE=not estimable due to too few events; SD=standard deviation; Q1=frst quartile; Q3=third quartile; * β
(SE) natural logarithm transformed for nonparametric distribution before reverse transform for interpretation  
Continued fom p. 41 
with older age, non-White race,
diabetes, hypertension, weight loss
>10% 6 months prior to surgery, and 
lymph node involvement (all respec-
tive p<0.05). There was a trend level 
association between MIS RPLND
and a higher proportion of chronic
steroid use, pre-operative transfu-
sion, and higher American Society of 
Anesthesiologists (ASA) classifcation
(all respective p<0.1). Multivariable
analysis detected no signifcant dif-
ference in rates of superfcial surgical 
site infection, 30-day mortality,
unplanned return to OR, acute care 
stay > 30 days, reoperation, read-
mission, or C. Difficile complica-
tions. MIS RPLND was signifcantly 
associated with 35 ± 9 minute shorter 
adjusted operative time and 51% ± 7% 
shorter adjusted hospital stay (respec-
tive p<0.05) (Table). RPLND volume 
has increased since 2005 (ρ= 0.724;
p=0.003) with the open approach
being utilized more often in recent
years (ρ= 0.101; p=0.013) (Figure). 
MIS RPLND demonstrated com-
parable perioperative outcomes to
open RPLND with decreased length
of hospital stay, despite higher burden
of comorbidities.  Although lymph
node yield could not be assessed within
the limitations of NSQIP, the shorter
operative time of MIS reinforces the
importance of thorough dissection
and adherence to template-based or
full bilateral dissection as indicated,
regardless of the surgical modality. 
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Robotic-Assisted Laparoscopic Approach to Radical 
Cystectomy Mitigates Surgical Complications in 
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There is growing evidence of the
adverse impact of preoperative 
malnutrition and hypoalbuminemia 
on perioperative and postoperative
complications fol lowing radica l 
cystectomy (RC) for the treatment
of muscle-invasive bladder cancer.
A robotic-assisted lapa roscopic
approach to RC is becoming more
widely used and, based on its reduced 
per ioperative morbid it y,  cou ld 
potentially be a preferable surgical
modality for patients with nutritional
deficits. Prior studies examining
the i mpact of ma l nutr ition on 
outcomes after RC have not explored 
the inf luence of surgical modality.
This investigation wil l evaluate
the associations of robot-assisted
surgical approach with perioperative 
a n d  3 0  - d a y  p o s t o p e r a t i v e  
complications after RC. It will also
evaluate the efects of preoperative
malnutrition and hypoalbuminemia 
o n  p e r i o p e r a t i v e  a n d  3 0  - d a y  
postoperative complications after
RC in the study cohort. 
Methods: Retrospective review of 
the American College of Surgeons
(ACS) National Quality Improvement
Database (NSQIP) identifed patients
who underwent RC with postopera-
tive diagnosis of bladder cancer and
non-disseminated disease (2005–18).1,2 
Surgical approach was categorized as 
open vs. robotic/laparoscopic. Given 
there is not a universally accepted
defnition of “malnutrition” we ana-
lyzed the data in multiple ways to
explore our hypotheses. The analysis 
was performed using a composite
group (low serum albumin (<3.5g/dL), 
10% 6-month preoperative weight
loss, or BMI <18.5 kg/m2) as well as a 
separate analysis for hypoalbumin-
emia only and there was not a sig-
nifcant diference in 
outcomes. Therefore,
likely to be older, female, current
smokers, have COPD and higher
American Society of Anesthesiology
(ASA) score. Regarding perioperative
complications, malnourishment was 
associated with greater preoperative 
transfusions, systemic sepsis, peri/ 
postoperative bleeding transfusions, 
30-day mortality, postoperative C.
difcile infection rate, and hospital
length of stay — despite actually
shorter operative time. In non-
ma l nourished patients: robotic
a pproach w a s a ss o ci ated w it h 
lower adjusted odds of bleeding
transfusion (aOR=0.39), return to
OR (aOR=0.55), and fewer adjusted
for this investigation, The typical benefts seen with robotic surgery
malnourishment
was defned as either translate to malnourished patients, although
h a v i n g low s er u m 
albumin (<3.5g/dL), they are still prone to longer hospital stay than
10% 6-month preop-
erative weight loss, their adequately nourished counterparts.
or BMI <18.5 kg/m2.
Multivariable logistic 
regression and generalized linear
models were used for categorical and
continuous outcomes, respectively, to
characterize the association between 
robotic-assisted surgical approach and
30-day perioperative/postoperative
complications following RC com-
pared to non-robotic operations. 
Results: Of 7,974 patients identifed,
730 (9.3%) were robotic-laparoscopic 
and 7235 (90.7%) were open. There
were 1370 (17.2%) ma lnourished
patients a nd 6604 (82.8%) non-
malnourished. In the 739 robotic
cases, 102 (13.8%) were malnourished. 
Malnourished patients were more
days from operation to discharge
(β[SE]= -1.3[0.3]) compared to open (all
respective p<0.05). In malnourished 
patients: robotic approach was 
associated with lower adjusted odds of
bleeding transfusions (aOR=0.51) and 
fewer adjusted days from operation to
discharge (β[SE]= -5.2[1.1]) compared
to open (all respective p<0.05). 
Conclusions: Robotic-laparoscopic
approach to RC mitigated two of
the postoperative complications
a s s o ci ated w it h m a l nut r it ion :  
bleeding transfusions and days from 
Continued on p. 44 
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Continued fom p. 43 
operation to discharge. The typical
benefits seen with robotic surgery
translate to malnourished patients,
although they are still prone to longer
hospital stay than their adequately
nourished counterparts. Further
improvements in per ioperative 
pathways are needed to optimize
the experience of malnourished
p a t i e n t s u n d e r g o i n g r a d i c a l  
cystectomy, especially given the
observed association with other high 
risk comorbidities. These findings
highlight the fact that a robotic
approach to RC may be preferable for 
patients with preoperative nutritional
defcits. 
REFERENCES: 
1.  R a v a l  M V, Pa w l i k  T M . P r a c t i c a l  
g uide to surgical data sets: National
Surgical Quality Improvement Program
(NSQIP) and Pediatric NSQIP. JAMA
Surg. 2018;153(8):764-765. doi:10.1001/ 
jamasurg.2018.0486 
2. Ingraham AM, Richards KE, Hall BL,
Ko CY. Quality improvement in surgery: 
The American college of surgeons national
surgical quality improvement program
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A Contemporary Analysis: Presenting Symptoms in  
Patients with a Vascular Ring and Predictors of
Symptom Resolution After Surgical Repair 
Vascular rings are rare congenital
anomalies of the aortic arch which
result from inappropriate embryo-
logic regression of the paired bran-
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FIGURE 1: Stratifcation of DAA and RAA patients by symptom severity  
indicates vascular anomalies that and patterns of symptoms associated echocardiography. Respiratory and
encircle the intrathoracic portion of with vascular rings, including severity GI symptoms were examined for
the esophagus and trachea.1 Vascular and time to symptom onset from their possible infuence on surgical
rings can cause respiratory or gastro- birth, and to determine predictors intervention and stratified using a
intestinal symptoms due to compres- of symptom resolution after surgery. severity score. 
sion of these structures, which are Methods: Single-center, 10-year Results: One hundred patients
expected to improve with surgical retrospective review of all patients with isolated complete vascular ring 
division. Advances in imaging tech- diagnosed with isolated vascular met inclusion criteria. Thirty-four
nology have resulted in early detection rings between Januar y 2010 and patients (34%) had a DAA and sixty-
in asymptomatic patients. This poses December 2019. Vascular rings were six (66%) had RALL. Seventy-five
new challenges for management of classifed as either double aortic arch patients (75%) were diagnosed after
patients with known vascular rings. (DAA) or right aortic arch with left presenting with respiratory or gas-
We sought to analyze the presence ligamentum arteriosum (RALL) by trointestinal symptoms; twenty-fve





















      
 
  








(25%) were asymptomatic at pre-
sentation, diagnosed incidentally.
Symptoms were stratifed by severity 
(Figure 1) and respiratory symptoms 
were found to be more frequent,
regardless of arch anatomy. 
Seventy-four patients (74%) under-
went surgical division of the vascular 
ring, out of which 99% (73/74) were
symptomatic. Forty-two patients
(63%) with RALL (n=42) received
surgical intervention compared to
thirty-two patients (94%) with DAA. 
Chi-square analysis found moderate/ 
severe respiratory symptoms pre-
dictive of surgery in patients with
a RALL (OR 6.0, p = 0.002). At a
median follow-up of 2.2 years, inci-
dence of overall symptoms decreased 
signifcantly in patients who under-
went surgical division (p<0.001); only 
28 patients (39%) exhibited persistent
symptoms. The incidence of respira-
tory symptoms, including stridor and 
recurrent respiratory infections, as
well as GI symptoms, decreased sig-
nifcantly in the postoperative period 
(p<0.001). There was no change in
the incidence of asthma symptoms in 
patients undergoing surgical interven-
tion (p=0.808). Neither age at opera-
tion (p=0.158) nor the anatomic type 
of the ring (p=0.332) were predictive 
of symptom resolution. The presence
FIGURE 2: Volume rendering of contrast-enhanced CTA in a A) 2-month-old with DAA
from a posterior view, and a B) 3-year-old with RAA-AbSA and diverticulum of Kommerell 
Both demonstrate compression of the trachea (yellow)  
of airway narrowing on pre-operative
bronchoscopy or computed tomog-
raphy resolved signifcantly postop-
eratively (62%, p<0.001). Incidence of
recurrent respiratory infections was
higher in the patients with residual
tracheal narrowing after surgical divi-
sion (3/20 vs 0/54;p=0.02). Survival was
100% (74/74). 
Conclusions: Surgical division of
the vascular ring leads to resolution
of obstructive symptoms in the vast 
majority of patients, with the excep-
tion of symptoms of asthma. Patients 
with symptomatic isolated vascular
rings should be ofered surgical inter-
vention; those who present predomi-
nantly with symptoms of asthma may 
not beneft from surgery. Although
RALL is more common than DAA,
the latter are more likely to undergo 
surgical intervention regardless of
symptom severity. Presence of post-
operative residual tracheal narrowing
predicts a persistence of respira-
tory tract infections, but not other
symptoms. A coordinated multidis-
ciplinary investigation of obstructive 
respiratory and gastrointestinal symp-
toms is necessary for early diagnosis of
vascular rings and appropriate referral
for surgical intervention. 
REFERENCES: 
1. Gross RE, Surgical relief for tracheal
obstruction from a vascular ring. N Engl J 
Med, 1945. 233: p. 586-90. 
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Cardiovascular Surgical Outcomes of Patients with Heterotaxy 
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Heterotaxy syndrome may be defned
as a spectrum of abnormally discor-
dant organ situs resulting from aber-
rant left-right axis determination in
the thoracic and abdominal cavities.1
The abnormal degree of thoracic
and abdominal visceral symmetry is 
associated with complex intracardiac
abnormalities, which may require
cardiovascular surgery early in life. We
sought to analyze outcomes of patients
with heterotaxy syndrome undergoing
cardiovascular surgical repair, with a
focus on univentricular palliation vs
full biventricular repair, and to deter-
mine predictors of mortality.
Methods: A single-center, 10-year 
retrospective review of all patients
diagnosed with heterotaxy syndrome 
who underwent cardiovascular sur-
gical repair from January 2008 to
December 2017. Diagnosis of hetero-
taxy syndrome was based upon evalu-
ation of thoracoabdominal situs by
echocardiography. Patients were clas-
sifed as either single ventricle (SV)
or biventricular (BV) according to
their functional anatomy after repair.
Univariate and multivariable Cox
regression analysis and Kaplan-Meier
analysis for survival were performed. 
Results: Eighty-two patients with
heterotaxy syndrome met inclusion 
criteria. Fifty-five patients (67%)
underwent SV palliation and twenty-
seven (33%) underwent complete BV
FIGURE: Overall Survival of Patients with Heterotaxy Sydrome 
repair. Patient mortality in the entire
cohort was 34% (28/82) including 36%
(20/55) for SV palliation and 30% (8/27)
for BV repair. Interstage mortality
among SV patients was 29% after
stage 1 (12/46), 17% after stage 2 (7/42),
and 4% after stage 3 (1/23). Among all
heterotaxy patients, independent risk
factors for mortality included pre- or 
post-operative ECMO (HR=10.4;
95% CI: 4.3-25.4; P<0.001), TAPVR
(HR=4.3; 95% CI: 1.7-10.8; P=0.002),
and body weight <2500g (HR=2.4; 95%
CI: 1.0-5.4; P=0.041). Among patients
undergoing SV palliation, signifcant
multivariable risk factors for mor-
tality included ECMO (HR=11.0; 95%
CI: 3.6-34.2; P<0.001) and TAPVR
(HR=7.0; 95% CI: 2.3-21.7; P=0.001).
Pulmonary vein stenosis was a sig-
nifcant univariate predictor of mor-
tality among all heterotaxy patients
(HR=3.0; 95% CI: 1.4-6.4; P=0.005) 
and in the subgroup of SV patients
(HR=4.0; 95% CI: 1.7-9.7; P=0.002).
Overall survival of all heterotaxy
patients was 66% (54/82) at a median
follow-up time of 2.2 years (0.4-4.1)
from the frst operation (Figure).
Conclusions: Despite advancements
in perioperative care and refnement of
cardiovascular operative techniques,
there is still considerable mortality in
children with heterotaxy syndrome in
the current era. Signifcant risk factors
for mortality in these patients include
body weight <2500g, TAPVR, and
ECMO, which may help to further
inform surgical decision-making.
Surgeons should proceed with caution
in patients with pulmonary vein ste-
nosis, as this is a signifcant predictor
of mortality irrespective of the func-
tional cardiac anatomy after repair.
There was comparable observed sur-
vival after the frst procedure, though
objective overall long-term survival
was higher in those who received
complete biventricular repair. Further
understanding of this complex patient
population is needed to overcome poor
prognostic factors and improve overall
long-term survival. 
REFERENCES: 
1) Peeters H, Devriendt K. Human laterality
disorders. European journal of medical
genetics. 2006 Oct 31;49(5):349-62. 





























     
 

























































    
 
 

























Is Epidural Analgesia Necessary for Unilateral Hip 












National Hospital Aribah Shah, MSII 
Proximal femur and pelvic osteoto-
mies are commonly used to correct
spastic hip dislocations in children
with cerebral palsy (CP). Treatment
of postoperative pain, in these often
cognitively impaired children, is chal-
lenged by difficulty self-reporting
pain.1,2,3 While undertreated pain
causes suffering, overtreatment can
precipitate respiratory compromise
in this vulnerable population.1,3,4 In 
patients with CP undergoing spine
surgery, epidural analgesia has been
shown to decrease intensive care unit
admissions due to respiratory decom-
pensation.4 Thus many centers are also
using epidural anesthesia for children
undergoing lower extremity surgery.
Epidural analgesia is often con-
tinued for 2-3 days, during which time
a Foley catheter is left in place until
the epidural catheter is discontinued.5
Neural-blockade in unilateral surgeries
often delays physical therapy, further
delaying patient discharge. This study
sought to determine if there was a
difference in pain control between
the use of epidural analgesia versus
non-epidural pain control modalities
for patients with neuromuscular condi-
tions undergoing unilateral hip recon-
struction. Additionally, we sought to
quantify diferences in length of stay
between the two populations. 
Methods: Following approval from
the Institutional Review Board, we
performed a retrospective chart review
of pediatric hip reconstructive pro-
cedures in which either epidural or
non-epidural analgesia was admin-
istered for postoperative pain relief.
We identifed patients who underwent
unilateral or bilateral proximal femoral
osteotomies, pelvic osteotomies, or
hip open reductions from Jan. 01,
2009 to Dec. 2, 2019, which yielded
227 patients. We excluded patients
who had a revision surgery and those
without neuromuscular conditions.
The fnal cohort consisted of 82 cases
that met all criteria, of which 66
underwent unilateral procedures.
Demographics, laterality of surgery,
postoperative pain control modality,
duration of pain control modality,
and length of stay at hospital were
recorded. Pain scores were recorded
using the FLACC pain scale.
Results: Of the patients undergoing
unilateral procedures, 37 used non-
epidural pain-control modalities,
and 29 used epidural analgesia. The
average ages of the epidural group and
non-epidural group were 8.82 years and
10.61 years, respectively. The epidural
group had median, mean, high, and low
pain scores for the length of their stay
of 3.5, 3.45, 5.93, and 1.31, respectively.
The epidural group had a mean length
of stay of 6.34 days. The non-epidural
group had median, mean, high, and low
pain scores for the length of their stay
of 3.43, 3.62, 6.27, and 1.77, respectively.
The non-epidural group had a mean
length of stay of 4.41 days. An unpaired
t-test was used to analyze the data, and
there were no signifcant diferences in
median (p=0.84), mean (p=0.52), high
(p=0.54), and low (p=0.09) pain scores
between the epidural and non-epidural
groups. There was also no signifcant
diference (p=0.09) in the length of stay
between the groups. 
Conclusion: There were no sig-
nifcant diferences in pain scores or
length of stay between the epidural
and non-epidural groups. 
Signifcance: These results suggest
that patients undergoing unilateral
hip reconstruction do not beneft from
epidural analgesia when compared to
non-epidural pain control modalities.
We are hopeful that this will allow
practitioners to standardize postop-
erative pain control in this patient
population. 
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Facial Nerve Dysfunction after Mandibular  
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Mandibular distraction osteogen-
esis (MDO) is a staged intervention
frequently used to address airway
obstruction in infants with Robin
Sequence (RS). Facial nerve dysfunc-
tion (FND) is a well-known but poorly
documented complication that may
occur during device placement/osteot-
omies, active distraction/lengthening, 
consolidation, and/or device removal.
The aim of our study was to precisely
and fully document this adverse event
in our recent experience to identify
possible risk factors that may be asso-
ciated with this increasingly popular
surgical airway procedure.
Methods: A retrospective review
of a prospectively gathered database 
was performed to identify patients
with RS that underwent MDO at
our institution from March 2013 to
June 2020. We included all infants
who did not exhibit FND, had early 
resolution of FND, or had FND with 
at least three months follow-up after 
device removal. Basic demographic
data and factors potentially related
to FND were documented, including 
onset, laterality, time to resolution,
and incidence of long-term palsy. 
Result s:  23 patients w ith R S 
were included in the analysis. 56.5%
of patients were female and the
majority of patients had an associated
syndromic diagnosis
(65.21%, n=15). Average
age at the time of 
d e v ice  pl a cement 
was 2.4 months. Mean
latency, distraction
a nd consol idation 
phase were 1.9 days,
 days, and 82.119.1
days, respectively. 
Mean distraction rate
was 1.2 mm/day. FND
was documented in 39.1% (n=9) of
patients, six of which were temporary.
The majority of FND cases occurred 
during the distraction phase and
one FND during the consolidation
period. FND persisted in 3 patients
for a mean of 25 months after device 
removal. All FND cases involved the 
marginal mandibular branch, with
one patient presenting with additional
involvement of zygomatic branch.
FND was not detected immediately 
fol lowing distractor placement/ 
osteotomies or device removal. 
Conclusions: FND associated with 
MDO for infants with RS is not
uncommon. Our study demonstrated 
that most cases of FND occurred
during the active distraction phase,
l ikely due to a stretch injur y of
the marginal mandibular branch. 
While the majority of FND cases
are transient, a small proportion
may persist. Future studies must
Our study demonstrated that most cases of 
FND occurred during the active distraction 
phase, likely due to a stretch injury of the
marginal mandibular branch.
aim to characterize risk factors for
FND, as well as identify strategies
for mitigating the risk of this adverse 
event. 
Objective: This study is the first
to characterize the prevalence of
permanent and transient facial nerve 
dysfunction experienced by a cohort 
of RS patients following MDO at a
single institution in recent years. 







































































Radiosurgery for Brain Metastases From Ovarian Cancer:  
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Cerebral metastases from gynecolog-
ical tumors are rare and usually develop
late in the course of the disease. The
incidence of brain metastases in
ovarian cancer is between 1% and 3%
with a recent increase likely related to
earlier diagnosis with modern imaging
techniques (CT, MRI, PET) and more
ef ective systemic therapies allowing
prolongation of the patient’s life.1,2 
Life expectancy in these patients is
poor. Typically, the treatment of brain
metastasis in patients with ovarian
cancer has consisted of a multimodal
approach including surgery, radia-
tion, and chemotherapy. Whole brain
radiation therapy (WBRT) for brain
metastases has not changed its poor
prognosis and very short survival.
Stereotactic radiosurgery (SRS) is
becoming a new paradigm in the man-
agement of these patients, in which
high doses of collimated radiation are
delivered by a linear accelerator or by
a Gamma Knife. 
A retrospective analysis of all
patients with ovarian cancer treated 
with Gamma Knife SRS (GKRS)
at outpatient centers from October
1993 to January 2019 was performed. 
Inclusion criteria included tissue-
confirmed diagnosis of epithelial
ovarian cancer with evidence of brain 
metastases as diagnosed by computed
tomography (CT ) and magnetic 
resonance imaging (MRI). Karnofsky
score (KPS), age at diagnosis, radio-
surgery dose, and survival time were 
analyzed. Of 872 women diagnosed
and treated for brain metastases in
the center, nine had primary ovarian 
cancer (1.03%). At presentation six of 
the nine patients had a KPS of 90%, 
one with 80% and two patients had no
documented score. The median age at
f rst treatment was 57 years old. 
TABLE: 
Characteristics  Median (range) Mean (range) Total Number   Percentage 
Age (years) 60 (39–79) 60 (39–79) 
KPS % 90 88 
90 7 78% 
80 2 22% 
No  of brain 
metastases 
2 (1–11) 3 (1–11) 
1 - - 4 44% 
>2 - - 5 56% 
Location of brain 
metastases 
45 
Supratentorial  - - 29 64% 
Infratentorial  - - 16 36% 
Tumor volume at 
GKRS (cm³) 
1  9 (0  4–30  3) 3  9 
Prescribed dose (Gy) 17 15  8 
Previous treatment  - - 9 100% 
Radiotherapy 
Chemotherapy  - - 9 100% 
Resection of primary  - - 9 100% 
Surgery of metastatic 
disease 
- - 2 22% 




Radiosurgery in these patients
was done by GKRS that delivers
a high-dose fraction radiation to
the target using Cobalt-60 as the
radioactive source. A stereotactic
frame fixed to the patient’s head
resulted in unsurpassed accuracy and
precision. A brain MRI with contrast 
was obtained immediately prior to
the treatment. The following organs
at risk were contoured: brainstem,
optic chiasm, optic nerves, lens and
any other of pertinent structure.
Forty-two metastases were treated
Continued on p. 50 
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Continued fom p. 49 
w ith 16 procedures in the nine 
patients. 
In this group of patients, the
interval between diagnosis of ovarian
carcinoma and development of brain 
metastases ranged from -1.0 to 125.5
months with a median of 31.5 months. 
The -1.0 stands for one patient whose 
brain metastasis was found prior
to the primary tumor. The median
overall survival time estimate from
original diagnosis of ovarian cancer
(OS2) was 48 months, ranging from
10.6 to 148.4 months. The median
overall survival after GKRS (OS1)
was 10.6 months ranging from 2.5 to 
81.1 months. 
Although this study should be
interpreted with caution because of
the limited number of patients, our
results are in accordance with the cur-
rent published literature. In general, 
the median survival after diagnosis of
brain metastases is usually six months;
nevertheless, better survival can be
achieved when multimodality therapy
FIGURE:
is used. GKRS is a valuable modality 
for management of brain metastases 
that is minimally invasive and well
in Oligometastatic Ovarian Cancer: A
Promising Therapeutic Approach. Int J
Gynecol Cancer. 2018;28(8):1507-1513 
tolerated. 2. Deng K, Yang C, Tan Q, et al. Sites of
distant metastases and overall survival in 
REFERENCES ovarian cancer: A study of 1481 patients. 
1. Iftode C, D’Agostino GR, Tozzi A, et al. 
Gynecol Oncol. 2018;150(3):460–465 
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A Retrospective Analysis of Trigger Point Injections in 
the Management of Post-surgical Pain in Patients 
Who Had Anterior Cervical Surgery 
Vivien Pat, MSIV
TABLE: Primary outcomes of anterior cervical surgery patients receiving postoperative 
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OME (mg) (mg) 
6 hours 32±2 8 (n=47) 22±3 0 (n=28) 0.025* 
12 hours 54±5 1 (n=29) 37±10 5 (n=9) 0 18 
24 hours 78±7 1 (n=27) 58±18 9 (n=6) 0 35 
VAS 
6 hours 3 4±0 4 (n=47) 3 3±0 4 (n=28) 0 78 
12 hours 5 3±0 6 (n=29) 4 2±1 3 (n=9) 0 45 
24 hours 5 4±0 6 (n=27) 3 2±1 5 (n=6) 0 21 
Data presented as Mean±Standard Deviation, OME: Oral Morphine Equivalent, VAS: 
The opioid epidemic has launched
the United States into a public health
crisis, resulting in a greater emphasis
on non-opioid multimodal pain con-
trol methods. At our institution, post-
operative posterior neck stifness and
myofascial pain is a common concern
after anterior cervical surgery (ACS),
likely due to prolonged intraoperative
positioning in neck extension. Studies
have shown successful analgesic
outcomes of trigger point injections
with local anesthetic for generalized
myofascial pain.1,2 This retrospective
pilot study aimed to evaluate whether
trigger point injections with bupi-
vacaine decrease postsurgical pain
compared with traditional therapies
in patients undergoing ACS and
thereby decrease the amount of opioid
medication used. 
Methods:  We retrospectively 
reviewed all ACS cases from January
2019 to Ma rch 2020 at a single 
university hospital. We identified
patients who received trigger point
injections with 0.25% bupivacaine
(TP) versus standard care (SC). In the 
TP group, only one TP was performed
and administered in multiple locations
along the bilateral trapezii and rhombi
Visual Analog Scale, * p-value was <0 05 
by an anesthesiologist. Patients were
excluded if TP was performed >3
hours from surgery, if patient was
in recovery for opioid use disorder,
under went a posterior approach,
staged surgery, or sustained cervical
trauma. The primary outcomes were
pain control through the Visual
Analog Scale (VAS) and calculated
oral morphine equivalents (OME)
taken at 6, 12, and 24 hours post-
operatively. Secondar y outcomes
included length of stay. Statistical
analysis was performed, and p-values
were based on Welch’s t-test. 
Results: There were 137 patients
who received anterior cervical surgery
(100 SC, 37 TP), and 62 were excluded.
A total of 75 (47 SC, 28 TP) patients
were included in this study. The
average age of patients was 56 years
old. The average OME at 6 hours was
signifcantly lower when comparing
SC vs TP (32 vs 22, p=0.025). There was
no signifcant diference in average
VAS at all time points and average
OME at 12 and 24 hours (Table).
50% of patients were discharged by
18 hours.
Discussion: Within six hours of
the postoperative period, TP led to
signifcantly lower opioid consumption,
without afecting overall pain level.
Therefore, in this retrospective study,
TP is an efective alternative opioid-
sparing method of pain control for
myofascial neck pain in the immediate
postoperative period after ACS. This
is an important consideration for pain
control management during the opioid
epidemic. 
Limitations of this retrospective
study were the small number of study
participants, that many patients were 
discharged before 18 hours, and that
some may have been on chronic pain
therapy. Using the lessons learned
here, a prospective double-blinded
randomized controlled study will be
designed and conducted to compare
with the results of this retrospective
study. Additionally, future studies can
continue to ascertain effectiveness
while also assessing for safety and
generalizability across other types of
surgeries.
Continued on p. 52 


































    
























Continued fom p. 51 to trigger points in myofascial pain syn-
drome. Rheumatol Int. 2005;25:604-11. 
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Many male patients have desired elim-
ination of their feminine-appearing
breast, termed gynecomastia. These 
patients have desired maximal fat-
tening of their chest. We present a
new set of patients who instead desire 
a more muscular-appearing chest
than a gynecomastia repair that is
interposed on a chiseled abdominal
contour. In contrast to the former
set of patients, these patients desire
bulking of their breasts with a bolder-
appearing armor plate look. We
present an alternative to traditional
gynecomastia repair which involves
a novel approach to chest contouring 
creating a fat, yet bold, pentagonal-
shaped breast with linear borders
utilizing both fat and gland removal 
as well as strategic fat grafting back
into the chest to create an armor plate
appearance. 
Methods: This study reviews the
technique of chest optimization on a 
cohort of 38 males with ages ranging 
from 21 to 62 years old (average, 37.5 
years old). Patients are treated with
a combination of intra-muscular and 
subcutaneous fat grafting strategi-
cally to create a pentagonal-shaped
FIGURE 1: Preoperative markings of chest masculinization protocol  Plus signs 
indicate regions where fat is added, whereas minus signs indicate regions fat will be 
subtracted This strategic placement of fat helps us to create a pentagonal-shaped chest 
with bold and linear borders 
chest with bold and linear borders
(Figure 1). Intramuscular fat injection
is performed along the vertical medial
line. This injection of fat into the
pectoralis muscle performed simul-
taneously with gynecomastia repair
allows for masculine appearance of
the chest. Fat graft amount ranges
between 60 and 350 cc injected to each
chest side (average, 150 cc). Tumescent
solution is used to infltrate and aspi-
rate (roughly 2–4 mL of solution for 
each milliliter of aspirated volume).
Average infltration varies between
100– 300 (right) and 100–280 (left)
with an average of 150 (both right
and left. Fat graft is grafted into the 
pectorals (10 cc injected into single
prominent inscription). Photographs
are taken at the 3- to 4-month mark 
for each patient. No complications
were found in all cases. 
Results: Below, we have demon-
strated three cases of an armor male 
chest contour interposed on a har-
monious masculinized abdominal
contour. All patients, 6-month post-
surgery, demonstrate a pentagonal
shaped chest with bold and linear
borders (Figures 2). Patients were
monitored, and no complications were
experienced.
Conclusion: The armor plate chest 
appearance provides a more mas-
culine male chest appearance. We
represent this alternative approach



























FIGURE 2: Male chest contouring to create a masculinized armor plate appearance 
A 34-year-old male three months following ultrasound-assisted liposuction of the 
abdomen, lateral chest, pubic region, and fat grafting to the chest  Patient demonstrates 
linear chest borders post-operation creating a more masculinized appearance 
to traditional gynecomastia repair
technique since it achieves a more
muscular-appearing chest contour
that is more harmonious on a male
patient u ndergoi n g abdom i n a l  
etching. Further monitoring and
precise evaluation of patients will
expand on the evaluation of fat-cell
survival and needed to determine the 
efcaciousness of this technique. 
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Total Octogenarians % Non- % p-value 
(n = 2222) (n = 1111) octogenarians 
(n = 1111) 
Anemia 429 227 20.43% 202 18.18% 0.179 
Arrhythmia w/ 347 231 20.79% 116 10.44% <0.001 
llfih. 
Arrhythmia w/o 155 93 8.37% 62 5.58% 0.009 
8All. 
Bleeding 20 12 1.08% 8 0.72% 0.368 
complication 
Blood 108 59 5.31% 49 4.41% 0.324 
Transfusion 
1 
Cellulitis 69 41 3.69% 28 2.52% 0.111 
MI 135 65 5.85% 70 6.30% 0.657 
Pneumonia 74 50 4.50% 24 2.16% 0.002 
Stroke 53 34 3.06% 19 1.71% 0.037 
Death 61 30 2.70% 31 2.79% 0.896 
DVT 77 39 3.51% 38 3.42% 0.907 
Heart Failure 200 117 10.53% 83 7.47% 0.012 
Pulmonary 49 26 2.34% 23 2.07% 0.665 
Embolism 
Respiratory 32 17 1.53% 15 1.35% 0.722 
Complication 
UTI 263 159 14.31% 104 9.36% <0.001 
Sepsis l 41 23 2.07% 18 1.62% 0.431 
Increased Complication Rates in Octogenarians  
Undergoing Same-Day Discharge Following Total  
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Same-day discharge pathways may
increase patient satisfaction and
reduce overall costs in total knee
arthroplasty (TKA).1,2 These path-
ways ofer potential advantages but
have not been thoroughly evaluated
in potentially at-risk populations,
such as in patients ≥80 years old.3 The
purpose of this study was to compare
90-day complications and mortality
following same-day discharge after
primary TKA in patients ≥80 years
old and those <80 years old.
Methods: Patients who underwent
unilateral TKA, were discharged 
on postoperative day 0, and had a
minimum 90-day follow-up were iden-
tifed in a national insurance claims
database (PearlDiver Technologies)
using CPT code 27447. These patients
were stratifed into two cohorts based
upon age: 1) non-octogenarians (<80
years old) and 2) octogenarians (≥80
years old). These cohorts were pro-
pensity matched based upon sex,
Charlson Comorbidity Index, and
obesity status. Univariate analysis was
performed to determine diferences in
90-day complications and mortality
between the two cohorts. 
TABLE: Univariate analysis of 90-day complications following same-day discharge 
after total knee arthroplasty  
*Bold values indicate statistical signifcance Afb: atrial fbrillation; MI: myocardial 
infarction; DVT: deep vein thrombosis; UTI: urinary tract infection  
Results: In total, 1,111 patients were
included in each cohort. Both cohorts
were successfully matched, with no
obser ved differences in matched
parameters for demographics or
comorbidities. There was no signif-
cant diference in 90-day mortality
between the two cohorts (p=0.896).
However, octogenarians were at sig-
nifcantly increased risk of postopera-
tive atrial fbrillation (20.8% vs. 10.4%;
p<0.001), pneumonia (4.5% vs. 2.2%;
p=0.002), and urinary tract infection
(14.3% vs 9.4%; p<0.001) compared to
the non-octogenarian cohort.
Conclusion: Relative to matched
controls, octogenarians are at sig-
nificantly increased risk of medical
complications within 90 days fol-
lowing same-day primar y TK A,
including cardiac arrhythmias, pneu-
monia, and urinary tract infection.
Clinicians should place emphasis on
the increased risk of these complica-
tions when counseling patients and
should practice careful patient selec-
tion when performing same-day TKA
in the octogenarian population. 
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Evaluating Postoperative Immobilization Following Hip 
Reconstruction in Children with Neuromuscular Conditions 
Aribah Shah,
MSII, and Kevin 
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Hip disorders, such as hip sublux-
ation, dislocation, and developmental
dysplasia of the hip, afect approxi-
mately one-third of children with
cerebral palsy (CP).1 These disorders
result from a combination of spastic
muscles placing abnormal forces on
the hip joint, resulting in subluxation
and bony deformities.2 Treatments
include non-operative (physica l
therapy, orthotics, medications) and
operative management.3 Femoral and
acetabular reconstructive surgeries
are the primary surgical interventions
for hip disorders in CP patients, but
there is no consensus on postoperative
immobilization method.4 
Postoperative protocols following
hip reconstruction in children with
CP include physical therapy, cast
immobilization (hip spica, petrie
cast), abduction pillows, and pain
management. Cast immobilization is 
used to achieve stability and prevent
early dislocation but poses risk of
serious orthopaedic complications.5
Currently, postoperative immo-
bilization method is determined
by surgeon preference. This study
sought to inform postoperative pro-
tocol by evaluating the effects of
several methods of postoperative
immobilization in patients with
neuromuscular conditions following
hip reconstruction and determining
which postoperative immobilization 
technique leads to the fewest number 
of complications. 
Methods: Following approval from
the Institutional Review Board, we
performed a retrospective chart
review of pediatric hip
reconstructive proce-
abduction pillow. Within the spica
group, 23% underwent hip proce-
dures, 10% underwent femur proce-
dures, and 67% underwent combined
hip and femur procedures. Of these
procedures, 53% included an open
reduction. Within the Petrie group,
6% underwent hip procedures, 17%
underwent femur procedures, and
77% underwent combined hip and
femur procedures. Of these proce-
dures, 60% included an open reduc-
tion. Within the abduction pillow
These results suggest that patients withdures in which either a
spica cast, Petrie cast,
or abduction pillow was neuromuscular conditions undergoing hip
placed for postoperative
hip immobilization. We reconstruction do not additionally beneft 
identifed patients who
under went unilateral from spica or Petrie casting in the setting 
or bilateral proximal
femoral osteotomies, where an open reduction is not performed. 
pelvic osteotomies, or
h ip open reductions 
from 01/01/2009 - 12/02/2019, which
yielded 227 patients. We excluded
patients who had a revision surgery
and those without neuromuscular
conditions. The final cohort con-
sisted of 82 cases that met all criteria.
Demographics, laterality of surgery,
type of procedure, postoperative
hip immobilization technique, and
30-day postoperative complications
were recorded. Complications were
defined as readmission to hospital
for a respiratory or orthopedic issue,
including but not limited to re-dis-
location or loss of surgical fxation.
Additionally, we included soft-tissue
complications, such as pressure ulcers
or any superficial or deep wound
infection.
Results: Of the 82 patients, 32
received spica casting, 35 received
Petrie casting, and 15 received an
group, 13% underwent hip procedures,
47% underwent femur procedures,
and 40% underwent combined hip
and femur procedures. Of these
procedures, 7% included an open
reduction. The complication rates,
as defined in the methods section,
were 21.9% for the spica cast group,
17.1% for Petrie cast, and 13.3% for
abduction pillow. A chi-squared test
was used to analyze the data, and
there was no significant difference
in complication rates among spica
cast, Petrie cast, or abduction pillow
groups (p=0.76). 
Conclusion: There was no sig-
nificant difference in complication
rates among the three methods of
immobilization. 
Continued on p. 56 
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Transfusion-associated hyperka-
lemic cardiac arrest (TAHCA) is an 
adverse outcome associated with red 
blood cell (RBC) transfusion. During
refrigerated storage, RBCs undergo a 
series of morphological, functional, 
and metabolic changes that are col-
lectively termed ‘the red blood cell
storage lesion.’ The RBC storage
lesion occurs in part to a progressive 
increase in extracellular potassium as 
cation transporters, including Na+/ 
K+ ATPase, are impaired during
hypothermic storage. Blood product 
irradiation further increases extra-
cellular [K+], as it increases the per-
meability of the RBC membrane.
Consequently, rapid or large volume 
transfusions can predispose patients 
to hyperkalemia and electrical insta-
bilities, including cardiac arrest.
Objective: We aimed to review the 















instabilities were more commonly
reported in pediatric patients if blood
products were transfused quickly,
were delivered directly to the heart
without adequate time for electrolyte
equilibration, or when blood products
had accumulated extracellular potas-
sium due to prolonged storage or
following irradiation. We note that
hyperkalemia and/or TACHCA may 
be underreported due to incomplete 
hemovigilance reporting systems.1 
Collectively, the 21 reports suggest
that the risk of hyperkalemia may
be mitigated by using fresh blood
products, reducing storage time
after blood product irradiation, and
implementing of post-transfusion
manipulations that wash or remove
excess extracellular potassium. 
Conclusion: Advances in transfu-
sion medicine have improved the
quality of RBCs during storage;
despite these advances, vulnerable
patient populations experience trans-
Advances in transfusion medicine have
improved the quality of RBCs during
storage; despite these advances, vulnerable
patient populations experience transfusion-
associated hyperkalemia.
fusion-associated hy perkalemia. 
Mitigation strategies may help to
reduce the risk of TAHCA, which
is associated with poor short-term
survival rate following rapid blood
administration.2 
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Autonomic Tone in Preterm Infants Correlates with 
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An appropriately mature autonomic
ner vous system (ANS) is key for
transition from the intrauterine to
seem to infuence ANS development
to term in a preterm population with
a relatively low level of prematurity-
related complications.1 GA at birth 
may therefore have less impact on
ANS development than previously
thought. Prior studies investigating 
ANS maturation in preterm infants
have predominantly involved infants
with higher levels of prematurity-
related complications,1,2 so it may be
that ANS development in the preterm
infant is more related to medical
comorbidities than birth GA. Given
recent evidence that GA at birth may
have less impact on ANS maturation
than previously thought, we hypoth-
esized that the medical complexity
of preterm infants
correlates with ANS 
maturation. For theUnderstanding how medical complexity
p u r p o s e s  of  t h i s  
study, we consideredimpacts ANS development in preterm infants
medical complexity
to i nclude a ny of may lead to future advances in NICU care. the following at any
extrauterine environment at birth,1 
and abnormal ANS development has
been linked to neurodevelopmental,
neuropsychiatric, and cardiovascular
outcomes later in life. The ANS
undergoes a critical period of matura-
tion during the latter half of gestation
and during the early neonatal period.
Previous studies have found that pre-
term birth and subsequent matura-
tion in the extrauterine environment
can impact A NS development.1,2 
However, it is likely that multiple
factors impact ANS development in
the extrauterine environment beyond
gestational age (GA) at birth. Our
group recently showed that duration
of extrauterine development did not
time during admis-
sion: culture positive 
infection, necrotizing enterocolitis
(NEC) diagnosis, presence of a patent
ductus arteriosus requiring medical
or surgical intervention or hemody-
namic instability requiring pressors,
brain injur y on head ultrasound
including periventricular leukoma-
lacia and intraventricular hemorrhage
grade 3 or 4, and need for mechanical
ventilation/intubation.
In this study, we set out to deter-
mine the degree to which com-
plications of prematurity impact
ANS development by comparing
114 preterm infants (birth GA ≤33
weeks) divided into two groups with
differing levels of complications of
prematurity. Group 1 included infants
without signifcant complications of
prematurity, while group 2 included
infants with medical or surgical com-
plications of prematurity. Weekly
electrocardiogram (ECG) data was
assessed from admission to neonatal
intensive care units (NICU ) dis-
charge. ANS tone was determined by
heart rate variability (HRV) analysis
in time and frequency domains.
Normalized low frequency, alpha 1,
and root mean square 1 characterized
sympathetic tone, while normalized
high frequency characterized para-
sympathetic tone. Median regression
with a group by time interaction term 
was used to model ANS maturation
across days of life and evaluate any dif-
ferences in maturation rates between
groups. 
Overall, we found that cohorts of
preterm infants with difering levels
of medical complexity show difer-
ences in their ANS development,
specifcally for time-domain metrics 
of HRV. The results indicated that
medical comorbidities, and, perhaps,
the negative experiences associated
with illness, do impact the trajec-
tory of ANS development in preterm
infants. Understanding how medical
complexity impacts ANS develop-
ment in preterm infants may lead to
future advances in NICU care. 
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A 52-year-old male with a past medical
history signifcant for hypertrophic
ca rd iomyopathy ( HC M ), atr ia l 
f ibr i l lation, hy per tension, a nd 
hy perl ipidemia presented to a n
outside hospital for pre-syncopal
episodes. Prior to presentation, he was
experiencing persistent, symptomatic
palpitations with heart rates in the
110s, and his verapamil dose was
increased from 120mg to 240mg
daily. In addition, the patient was
also being managed with metoprolol
tartrate 100mg BID, amiodarone,
and rivaroxaban. The patient arrived
at the hospital with shortness of
breath, cyanosis, hypotension, and
bradycardia. He endorsed alcohol
use the day before with burning
abdominal pain and weakness at
that time. He was subsequently
int ubated, paced, a nd required 
pressor support with norepinephrine
and epinephrine. His verapamil
was also held at this time. His labs
are listed in the table below. Given
his worsening liver function tests,
and a Model for End-Stage Liver
Disease (MELD) Score of 39, he was
transferred to a transplant center
for evaluation for liver transplant.
Liver biopsy was consistent with
hypoxic injury. Extensive workup
for other etiologies of liver failure,
including viral hepatitis panel, and
autoimmune hepatitis panel were
FIGURE: Mechanism of action of DHP (A) and non-DHP (B) calcium channel blockers 
(Wecker, 2019, pp  325-329) 
a l l negative. The patient’s l iver 
function continued to improve over
the course of his hospitalization
without need for transplant, but
renal function did not recover, and
he was transferred to our facility for
hemodialysis initiation. He continued
to remain in atrial fbrillation over
the course of the hospitalization with 
heart rate sustained in 140s bpm.
His metoprolol tartrate dose was
increased to 125mg BID for better
rate control. His hospital course was
otherwise complicated by Klebsiella
venti lator-acqu i red pneu mon ia 
( VAP) and post-traumatic stress
disorder (PTSD) from the protracted
hospital course. 
Discussion: Verapamil is a calcium
channel blocker commonly used
to treat hypertension and provide
rate control for atrial fibrillation/ 
f lutter. It has a strong affinity for
both myocardial and vascular smooth
muscle, allowing it to exert its efects
not only on the musculature of the
heart but also on arterioles throughout
the body. The therapeutic mechanism
is primarily vasodilation, along with
suppressing cardiac contractility,
sinoatrial node automaticity, and
atrioventricular node conduction.1 
While this potent vasodilation
is efective in treating patients with
hypertension, it also poses a signifcant
risk profle when taken at doses over
the therapeutic range, most notably
causing bradycardia, hypotension,
cond uc t ion d i st u r ba nce s ,  a nd 
escape rhythms. When progressive,
hypotension and bradycardia can
eventually lead to cardiogenic shock.1 
C o m b i n a t i o n  t h e r a p y  i s  
ver y commonly used to manage 
Continued on p. 60 








































    
Continued fom p. 59 
v a r i o u s  m e d i c a l  c o n d i t i o n s ;  
however, polypharmacy inherently
increases the risk of adverse events.
C a r d i o g e n i c  s h o c k  h a s  b e e n  
reported as a rare complication
associated with the use of verapamil
a nd b et a - blo c ker s .  Ver a pa m i l  
produces a state of myoca rd ia l 
depression, which is usually not
problematic due to a compensatory
sympathetic ref lex.2 However, the
co-administration of beta-blockers
blunts this compensatory mechanism,
potentiating myocardial depression, 
thus posing an increased risk for
cardiogenic shock.3 
The aforementioned principles
out l i ne  t he  r i s k s  p os e d w hen 
taking doses over the threshold for
therapeutic treatment.4 The case 
presented here remains unique as
the dosage for both the metoprolol
a nd verapa m i l were w ith in the 
therapeutic range. Therefore, while
rare, it is important to up-titrate
these medications with caution and
consider the risk for cardiogenic
shock with potential for end-organ
TABLE: Laboratory Results 
BUN 71 
Cr 7 2 
BUN/Cr 9 
PT 57 2 
INR 6 42 
PTT 42 9 
Tbili 1 6 
AST 13,112 
ALT 9,553 
Troponin I 0 047 

















damage even when delivered within
the therapeutic window. 
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Objective: To measure the association
of race, ethnicity, comorbidities, and
insurance status with need for hospi-
talization of symptomatic Emergency
Department ( ED) patients with
Severe Acute Respiratory Syndrome
C or on a v i r u s  2  ( S A R S - C oV- 2)  
infection. 
Methods: This study is a retro-
spective case-series of symptomatic
patients presenting to a single ED with
laboratory-confrmed SARS-CoV-2
infection from March 7 to Aug. 9,
2020. We collected patient-level
information regarding demographics,
public insurance status (Medicare or
Medicaid), comorbidities, level of care
and mortality using a structured chart
review. We compared demographics 
and comorbidities of patients who
were (1) able to convalesce at home,
(2) required admission to general
hospital ward, (3) required admission
to intensive care unit (ICU), or (4)
died within 30 days of the index visit.
Multivariable and univariable logistic
regression analyses were performed
to report adjusted odds ratios (aOR)
and the associated 95% confidence
inter vals (95% CI) with hospital
admission versus ED discharge home
and need for intensive care unit (ICU)
admission versus general hospital ward
admission.
Results: In total, 993 patients who
presented to the ED with symptoms
were included in the analysis with
370 (37.3%) patients requiring hos-
pital admission and 70 (7.1%) patients
requiring ICU care. Patients requiring
admission were more likely to be Black
or African American, to be Hispanic
or Latinx, or to have public insur-
ance (either Medicaid or Medicare.)
In multivariable logistic regression
analysis comparing which patients
required hospital admission, Black
race (aOR 1.4, 95% CI 0.7-2.8) and
Hispanic ethnicity (aOR 1.1, 95% CI
0.5-2.0) were associated less with need
for admission than public insurance
(Medicaid: aOR 3.4, 95% CI 2.2-5.4;
Medicare: aOR 2.6, 95% CI 1.2-5.3;
Medicaid and Medicare: aOR 3.6
95% CI 2.1-6.2) and the presence of
hypertension (aOR 1.8, 95% CI 1.2-
2.7), diabetes (aOR 1.6, 95% CI 1.1-2.5),
obesity (aOR 1.7, 95% CI 1.1-2.5), heart
failure (aOR 3.9, 95% CI 1.4-11.2), and
hyperlipidemia (aOR 1.8, 95% CI 1.2-
2.9) were identified as independent
predictors of hospital admission.
When comparing those who needed
ICU admission versus general hospital
ward admission, Medicaid (aOR 2.2,
95% CI 1.0-5.1) and Medicare (aOR 2.0
95% CI 0.7-5.8) were associated with
ICU admission but Black patients
were less likely (aOR 0.6 95% CI
0.1 - 2.4) and Hispanic patients were
weakly (aOR 1.05 05% CI 0.54 - 2.02)
associated with ICU admission. 
Conclusion: Comorbidities and
public insurance are predictors of
more severe illness for patients with
SARS-CoV-2. This study suggests
that the disparities in severity seen
in coronavirus (COVID-19) among
Black and Hispanic patients may be
attributable, in part, to low socio-
economic status and chronic health
conditions.
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University, School of Medicine and Health
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Quinolones are antibiotics used
for a wide array of infections.1,2 
Nevertheless, their side efects have 
resulted in changes in quinolone
administration by providers.3 In this 
study, the trend of quinolone utiliza-
tion over the years in the emergency 
department (ED) was analyzed. 
A review of the National Hospital 
Ambulatory Medical Care Survey
(NHAMCS) database was performed.
Using drug codes provided by the
Centers for Disease Control and
Prevention (CDC), all patients 18
years and older who were adminis-
tered or prescribed quinolones were
identified between 2005 and 2015.
Bivariate and multivariate statistical
analyses were used to analyze the
demographics, payment source, and
hospital disposition of the study popu-
lation. Reasons for ED visit and fnal 
diagnoses were also examined. 
In 2005, quinolone was admin-
istered during 2.8 million visits,
accounting for 2.4% of all ED visits.
From 2005 to 2009, quinolone utiliza-
tion experienced an average relative
increase each year of 4.5%. From 2010-
2015, quinolone use had an average
relative decrease each year of 3.2%.
In 2015, quinolone was administered
during 2.7 million visits (1.9% of all
ED visits, P<0.0001). 




adults, ages 45- 64
(2 0.1% a nd 1 .5 %,  
P<0.0001), whereas
its use increased in
older adults, ages 65+
(1.8%, P<0.0001).  
Quinolone utilization
increased for males
(1.3%, P<0.0001) and 
decreased for females
(10.8%, P<0.0001), with its use more
common in females (56.8%-59.9%).
Quinolone use increased in patients
with Medicare and Medicaid (2.7%
and 18.7%, P<0.0001), while its use
decreased in those with self-pay and
private insurance (13.0% and 41.9%,
P<0.0001). Compared to the patients
in 2005, the patients in 2015 who
received quinolones had increased
odds of returning to the ED within 72
hours after discharge (OR 0.7, 95% CI
2.8-9.1, P<0.0001). The patients in 2015
were also less likely to be admitted to
the hospital (OR 1.2, 95% CI 19.1-36.4,
P<0.0001). The most common reason
for visit where quinolone was used
was abdominal pain (9.2%-11.7%).
The most common fnal diagnosis was
urinary tract infection (12.9%-15.5%). 
EDs are prescribing less quino-
lones for their patients due to their side
efects and black box warnings, such as
altered mental status and aortic rup-
EDs are prescribing less quinolones for their 
patients due to their side effects and black
box warnings, such as altered mental status 
and aortic ruptures. Future research should
focus on concomitant increase in other drugs 
to replace quinolones in the ED. 
tures. Future research should focus on
concomitant increase in other drugs to
replace quinolones in the ED. 
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Determining Whether an Individual’s Age or Comorbidities is 
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To date, the SARS-CoV-2 coronavirus
(COV ID -19) has rapid ly k i l led 
over a million people worldwide.1 
Researchers identified elderly age
and various comorbidities as early
risk factors for mortality. Patterns
observed in Wuhan and early cases
in the United States indicate that the
risk of death increases in those over
65 years old, as well as individuals in
any age group with comorbidities,
including diabetes, heart disease,
and clotting disorders.2 In fact, the
study reported that the mortality
rate for COVID-19 patients is 7%
in people with diabetes, 10% in
people with heart disease, and 15% in
people ≥ 80 years old. Additionally,
for those with cancer, hypertension,
or chronic respiratory disease, the
mortality rate rises to 6% from 1%
in the general population.2 Due 
to the inf lux of patients requiring
hospitalization and advanced airway
management (e.g., intubation and
mech a n ica l  venti l at ion),  m a ny 
hospitals faced supply shortages
early on in the pandemic. In resource
limited settings over whelmed by
a heavy infection burden, such as
various regions of Italy, reports
emerged of rationing ventilators
and even withholding life-saving
interventions from individuals over
a certain age cut-of.3 This begs the
question of whether healthy elderly
individuals have increased mortality
over their younger counterparts
w ith comorbid conditions. The
Charlson Comorbidity Index (CCI)
is a popular risk adjustment tool for
10-year survival in patients. However,
applying the CCI to COVID-19
patients has not yet been probed.
The objective of this study was to
determine whether age or the CCI
is superior in predicting mortality in
COVID-19 patients. 
Methods: Between March and
July 2020, a prospective registr y
containing all COVID-19 admissions
to the George Washington University
Hospital was created. A receiver
operator characteristic (ROC) curve
was created for both age and CCI as
a predictor of mortality. Data was
then divided into age brackets with a
breakdown of CCI quartiles for each
bracket. 
Results: In total, 369 patients
were studied. Mean age was 61.5
years and CCI was 3.91. The ROC
curve for CCI yielded an Area under
the Curve (AOC) of 0.6476 (0.57– 
0.72), while that for age yielded an
AOC of 0.6737 (0.60–0.75). ROC
contrast estimation of these two
predictors did not indicate that
one was significantly better than
the other. When age groups were
analyzed by CCI, there were certain
healthy older age groups with better
survival than their younger, comorbid
counterparts. For example, ≥ 91-year-
olds with a lower quartile CCI (0–5,6)
had a 0–33.3% mortality rate. This is
better than 81–90-year-olds with a
CCI of 7 (57.1%) or CCI ≥ 9 (75%) and
even mortality rates in 61–70-year-
olds with a CCI of 5–6 (53.8%) and
7–10 (50.0%).
Conclusions: Both age and CCI are
significant predictors of mortality
for the population represented in
this registry. Comparing the two
did not show a signifcant mortality
difference. However, our study
suggests that one must reconsider
withholding treatment from the
healthy elderly population, as these
patients may have better survival
t h a n t hei r  you n g er,  but  more 
comorbid, counterparts. Data may
be confounded by our institution
admitting transfers from outside
institutions and more elderly patients 
being made DNR/DNI or CMO than
younger patients. Further studies are
needed to evaluate these trends and to
possibly look at the entire COVID-19
population in Washington, D.C.,
rather than just those admitted to
the hospital.
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Evaluation of Thromboelastography in 
Patients with Gastrointestinal Bleeding 
TABLE 1: Blood Product Utilization in TEG and non-TEG patients 
Alex Jett, MSII 
TEG Non-TEG 
All Patients 
Mean pRBC  - Days 0 and 1** 2 93 5 622 
Mean FFP - Days 0 and 1** 0 469 2 49 
Mean All Productsa - Days 0 and 1** 3 59 9 09 
Negative Binomial Regression 






Srinivasa, MSII, Marcinkowski, MSII 
ADVISORS: Ghazi
Rizvi, MD;1 and






University Hospital MSII 
Nandan Srinivasa,
Thromboelastography (TEG) is a
low-cost, point-of-care diagnostic
test used to quantitatively assess
platelet function, clot formation,
and fibrinolysis. TEG is increas-
ingly employed to guide transfusion
therapy in trauma and surgical cases
to decrease mortality and blood
product transfusion.1,2 These popula-
tions are distinctly diferent from the
medical population, which carries dif-
ferent comorbidities, risk factors and
baseline antiplatelet/anticoagulant
use. The most common subset of med-
ical patients with acute bleeding are
those with gastrointestinal bleeding
(GIB). To our knowledge, the utility
of TEG in patients with GIB is not
a pRBC plus cryoprecipitate plus platelets plus fresh frozen plasma (FFP) 
** p < 0 01 
well described to date. We sought to
assess whether TEG has a beneft in
patients with clinically significant
GIB by examining blood product
utilization. 
Methods: A retrospective chart
review was performed on patients who
were admitted between 01/01/2017
and 12/30/2019 to our intensive care
unit with an ICD 10 diagnosis code
of “hematemesis” 
( K92.0), “melena” 
of a transfusion-dependent anemia
or hematological disorder, had a left
ventricular assist device, were in car-
diac arrest on admission, or had pre-
sumed shock from a non-hemorrhagic
etiology.
Results: TEG patients had signif-
cantly greater numbers of total blood
products (packed red blood cells
(pRBC), cryoprecipitate, platelets,
(K92.1), or “gastroin- The use of TEG for patients presenting with GIB
testinal hemorrhage,
unspecific” (K92.2). resulted in increased pRBC and FFP transfu-
Patients greater than
18 years of age were sions without any change in clinical outcomes 
included in the study
if they had a clini- as compared to the standard of care.cally signifcant GIB,
defned as receiving
an administration 
of a blood transfusion for the GI
bleed.3 After this initial stratifica-
tion, patients were excluded from the
study if they were DNR/DNI and/ 
or comfort care status on admission,
had received a documented blood
transfusion in the preceding two
weeks, presented as a trauma, had
respiratory failure or mechanical ven-
tilation on admission, had a history
and fresh frozen plasma (FFP)) trans-
fused than the non-TEG patients
during GIB days 0 and 1 (mean 9.09
vs. 3.59, p < 0.01). This diference was
primarily driven by differences in
pRBC (mean 5.622 vs. 2.93, p < 0.01)
and FFP (mean 2.49 vs. 0.469, p <
0.01). Cryoprecipitate (mean 0.295
vs. 0.015, p < 0.01) and platelet usage
(mean 0.688 vs. 0.18, p < 0.01) in











































TEG patients was also signifcantly
higher than in non-TEG patients
on bleed days 0 and 1. Multivariate
analysis revealed that TEG patients
still received a greater total number
of blood products during GIB days 0
and 1 compared to non-TEG patients
(mean 6.42 [95% CI 4.48-8.36] vs.
4.00 [95% CI 3.19-4.80], p < 0.01) even
when controlled for the following
covariates: vasopressor use, sex, race, 
age, total comorbidities, shock index, 
hemoglobin on admission, platelet
level, hemorrhage control, alcohol
abuse, cirrhosis, abdominal surgeries,
cerebrovascular disease, and malig-
nancy (Table 1). The clinical outcomes
for patients in the TEG and non-TEG
arms were not signifcantly diferent
for most parameters (Table 2). 
Conclusions: The use of TEG for
patients presenting with GIB resulted
in increased pRBC and FFP transfu-
sions without any change in clinical
outcomes as compared to the stan-
dard of care. Our fndings underscore
the need for a randomized controlled
trial to further elucidate the role
of TEG in medical patients before
routine adoption of its use in these
patients. 
TABLE 2: Patient Clinical Outcomes 
* p < 0 05 
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Retrospective Review Characterizing the 
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This study aims to characterize the
diseases seen in a multispecialty pedi-
atric dermatology-gynecology vulvar
clinic at Children’s National Hospital
(CNH) in Washington, D.C. Though
dermatologic fndings involving the
vulva may present to a variety of
practices, ranging from pediatric pri-
mary care, dermatology, gynecology,
or urology, few training programs
provide significant training on the
interdisciplinary knowledge needed
to accurately diagnose pediatric
vulvar dermatologic diseases. To our
knowledge, very few multispecialty
clinics bring together dermatology
and gynecology, especially in a pedi-
atric setting. Based on experience
in our multidisciplinary pediatric
dermatology-gynecology vulvar clinic,
we aim to highlight the benefts of a
multispecialty clinic and showcase the
conditions diagnosed, managed, and
treated. Additionally, we will explore
relevant epidemiological factors seen
in this patient population.
Methods: We conducted a retro-
spective review of 180 patient charts
from pediatric patients seen at the
joint dermatology-gynecology clinic at
CNH, at least once between January
2016 and June 2020. Data collected
from the charts included patient
diagnosis, demographics, vulvar symp-
toms, and prior care related to the
patient’s vulvar symptoms. Data was
entered into a RedCap database and
analyzed. 
Results: Among the 180 patients
seen (mean age 6.89 ±SD 4.63), the
three most common conditions seen
in the clinic are as follows: pediatric
vulvar lichen sclerosus (PVLS) (69.9%),
vitiligo (21.69%), and vulvovaginitis
(21.69%). In total, 83 conditions were
evaluated in this multispecialty clinic.
Approximately 17.8% of patients with
pediatric lichen sclerosis
highlights the variety of conditions 
seen and complexity of care faced in
a pediatric dermatology-gynecology 
clinic, with emphasis on the risk
for a delay in diagnosis when vulvar
symptomatolog y is diagnosed in
patients seen outside of a dermatology-
gynecology clinic initially. Enhanced
training at the pediatric primary care
level is needed to help guide clinicians
in accurately diagnosing pediatric
vulvar complaints. 
Keywords: Pediatric dermatology, 
pediatric gynecology, multispecialty 
clinic, pediatric vulvar lichen scle-
rosus, vitiligo, vulvovaginitis, vulvar 
care. 
and 38.9% of patients with Our study addresses a gap in published 
vitiligo were misdiag-
nosed at least once. On in f o r ma t io n  o n  p e dia t r i c  v ulv a r  average, from the time of
symptom onset to a diag- symptoms and patient characteristics innosis, those with PVLS
wa ited 1 4 .58 mont h s 
a multispecialty dermatology-gynecologyand those with vitiligo
waited 10.29 months until
interdisciplinary clinic.diagnosis. Of those with
PVLS who frst received
a misdiagnosis, 92.8% of
the time the diagnosis was made out-
side of the dermatology-gynecology
clinic. Of those with vitiligo who frst
received a misdiagnosis, 75.0% of the
time the diagnosis was made outside of
the dermatology-gynecology clinic. In
the paper, epidemiological factors for
the clinic as a whole and for the three
most common diseases are discussed. 
Conclusion: Our study addresses
a gap in published information on
pediatric vulvar symptoms and patient
characteristics in a multispecialty
dermatology-gynecology interdis-
ciplinary clinic. The chart review
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Ocular corticosteroids are ubiq-
uitous medications used to treat
a wide variety of conditions that
were previously vision-threatening,
including uveitis, diabetic macular
edema (DME) and retinal vein occlu-
sion (RVO). Despite the therapeutic 
value of these medications, they often
induce the elevation of intraocular
pressure (IOP), leading to progres-
sive ocular nerve damage and, in
some cases, to corticosteroid-induced
glaucoma. 
For patients in the general popula-
tion without glaucoma, an estimated 
one-third of the population may
be considered “steroid responders,”
indicating that treatment with a
steroid would lead to an increase in
IOP.1 Of the two primary formula-
tions of ocular steroids, topical and
intravitreal, the latter often results in 
clinically signifcant IOP elevation, 
threatening vision. Although certain 
risk factors have been identifed as
predictors for corticosteroid response,
the variability of outcomes among
individual patients continues to
render the decision to initiate intravit-
real corticosteroid treatment difcult.
One method for assessing an indi-
vidual’s potential risk of developing a 
steroid response following intravitreal
injection may be the evaluation of that
patient’s IOP following the adminis-
tration of a topical corticosteroid. Of 
the topical corticosteroids available on
the market, Durezol
(difuprednate) is one 
of the most potent,
contributing to its
utility as an adequate 
challenger to elicit
s te r o id  r e s p o n s e .  
Thus, we hy pothe-
sized that we could
identify intravitreal
steroid responders as 
individuals who expe-
rienced elevated IOP 
following administra-
tion of Durezol topical corticosteroid.
A prospective cohort study of
29 patients diagnosed with DME or 
RVO over four years (2016-20) was
conducted. IOP was measured at
baseline and at four weekly intervals 
following topical corticosteroid treat-
ments. After a two-week washout
period, intravitreal corticosteroid
injection was administered, IOP
was then measured at three intervals 
post-injection: 2-4; 4-8; 8-12 weeks.
After excluding nine patients with
incomplete steroid courses, linear
models and corresponding plots
were generated for 20 patients using 
R open-source software. Baseline
IOP was not a statistically signifcant 
predictor of IOP elevation after treat-
ment. Regressing average IOP for
the four weeks following intravitreal 
injection compared with the average 
IOP for the 3-week intervals following
topical corticosteroid administration
yielded an estimated slope of 0.72 with
95%CI of (0.46, 0.99) and R2 =0.57. 
For patients in the general population
without glaucoma, an estimated one-third 
of the population may be considered “steroid
responders,” indicating that treatment with a
steroid would lead to an increase in IOP.1 
This study suggests that post-top-
ical corticosteroid IOP response is a 
good predictor of the post-intravitreal
corticosteroid IOP response, inde-
pendent of baseline IOP, making it a 
potentially useful screening process
for predicting steroid responders. 
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The Role of Regulatory T-Cells in Exercise-Induced 
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Chikungunya virus (CHIKV) is an
arbovirus that causes fever, rash,
myalgia, arthralgia and persistent
arthritis. CHIKV arthritis is sym-
metric with relapsing-remitting
symptoms mirroring rheumatoid
Our studies are consistent with recent
Treg depleted murine models of arthritis 
showing that voluntary running might
play a role in switching off the Treg-
mediated resolution of arthritis leading
to increased joint infammation.3 
arthritis. In our prior published study
of a diferent cohort, we found that
39% of CHIKV arthritis patients
reported relapses of CHIKV arthritis
due to exercise.1 The underlying 
mechanism of exercise-induced viral 
arthritis (EIVA) relapses is unknown.
The objective of this analysis is to
examine the regulatory T-cell (T-reg) 
immune response related to CHIKV 
arthritis fares. 
Methods: On hundred twenty-
four Colombian patients with a his-
tory of CHIKV infection four years
prior were enrolled (approved by
The George Washington University
Institutional Review Board#121611
and the Clinica de la Costa IRB,
Colombia (FWA IORG0008529)).
Eleven patients were excluded from
the analysis due lack of serologic con-
frmation of CHIKV infection (n=9),
lack of blood sample (n=1), or lack of
information on exercise efects (n=1).
One hundred thirteen cases were
analyzed. Demographic factors and 
measures of arthritis disease severity
are reported. Flow cytometr y of
T-cells was performed on
a BD Celesta fow cytom-
eter (BD Biosciences, San
Jose, CA) and analyzed in
FlowJo 10 (TreeStar Inc.,
Ashland, OR). We com-
pared outcomes in CHIKV
patients with (n = 38) vs.
without (n = 75) EIVA using
t-tests to assess means and
the Fisher’s exact test and
chi-squared to evaluate cat-
egorical variables (SAS 9.3). 
Results: CHIKV cases
w e r e  p r e d o m i n a n t l y  
middle-aged Mestizo females with
at least secondary school education
without history of arthritis prior
to CHIKV infection. 33.6% of the
CHIKV cases reported worsening
arthritis with exercise. EIVA patients
reported higher global assessments
of arthritis disease ranging from
0-100 (71.2±19.7 vs. 59.9±28.0, p=0.03).
Phlebotomy obtained under resting
conditions revealed that patients with
worsening arthritis from exercise had
lower levels CD4+ T-cells (149,556±
78,196 vs. 186,457±92,167, p= 0.04),
and lower ratios of Tregs/CD4+ T-cells
(1.95±0.73 vs. 2.4±1.29, p = 0.04). 
Conclusions: These findings sug-
gest that relative decreases in Treg
populations in patients with CHIKV
arthritis may contribute to arthritis
fares during exercise. Treg cells are
stimulated by exercise in humans and
are suggested to play an acute anti-
infammatory role.2 Our studies are
consistent with recent Treg depleted
murine models of arthritis showing
that voluntary running might play a
role in switching of the Treg-mediated
resolution of arthritis leading to
increased joint infammation.3 Studies
of exercise challenge in this popula-
tion are needed to further defne the
immunologic relationship between
CHIKV arthritis and exercise.
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Chikungunya virus (CHIKV) is a
mosquito-borne virus that causes
persistent arthritis in approximately 
one-fourth of patients.1 Preliminary
data suggests that alteration of regu-
latory T cell function may play a role 
in CHIKV arthritis f lares. There
is currently no standard treatment
for this arthritis. The objective of
this analysis is to determine what
treatments are being used currently
by patients and which of those treat-
ments are associated with control
of arthritis symptoms in a Latin
American cohort.
We performed a cross-sectional
analysis of self-reported medication
use and symptom relief among 114
patients afected by CHIKV infection
from Atlántico, Colombia for years
prior. This study was approved by the 
ethics committee of the Clinica de
la Costa (FWA IORG0008529) and
The George Washington University
(#121611).
All participants in the study were
mestizo in ethnicity. One hundred
four of 114 patients (91%) reported
years of persistent arthritis attrib-
uted to their CHIKV infection from
infection 4-5 years prior. Participants
reporting persistent arthritis were
predominately women with a mean
age of 48. Of those with
persistent arthritis, 26%
reported using medicinal
plants or alternative medi-
cine therapies. However, of
those that reported having
their symptoms controlled,
methotrexate and medicinal
plants were the most com-
monly used therapeutics.
Only 66% of patients with 
arthritis reported that the
therapies they were using
were able to control their
symptoms. The most com-
monly used medications
were paracetamol/acetaminophen
(94%) and NSAIDS (81%) — and the
least commonly used was metho-
trexate (1%).
With the results showing a better 
control of symptoms in patients
taking methotrexate or medicinal
plans, versus other treatment thera-
pies, further trials are needed to
investigate effectiveness of metho-
trexate, medicinal plants and alter-
native medicine therapies to deter-
mine pathophysiology and efficacy
in alphaviral arthritis. Analysis of
the longest follow-up of the largest
cohort of patients with relapsing-
remitting chikungunya arthritis
in Latin America demonstrates a
lack of arthritis symptom control in 
over one third of patients. Over one 
fourth of patients reported using
medicinal plants however little is
known about the mechanism of
action of various local medicinal plant
therapies such as including Plantago 
major L. and Terminalia catappa L.
in the treatment of CHIKV arthritis.
Although both French and Brazilian 
guidelines both advise use of metho-
trexate in the treatment of chronic
Analysis of the longest follow-up of the
largest cohort of patients with relapsing-
remitting chikungunya arthritis in Latin
America demonstrates a lack of arthritis
symptom control in over one third of
patients. 
CHIKV arthritis, there is no stan-
dard evidence-based guidelines for
the treatment of CHIKV arthritis in 
Colombia and very few patients were 
using immunomodulating therapy.2 
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Fetal intracranial hemorrhage (ICH) 
is a rare condition, with an estimated 
incidence of 0.5-0.9 per 1000 pregnan-
cies, that has potentially severe con-
sequences.¹ Previous studies on fetal 
ICH show it has a 40% mortality in 
utero or within the frst month of life 
and less than 50% of survivors are neu-
rodevelopmentally normal.² Existing 
literature defnes fetal ICH and out-
come based on prenatal ultrasound,
however fetal MRI is increasingly
used for clinical prenatal diagnosis
and may aid in detection.³ Our objec-
tive was to understand pregnancy and
child outcomes following fetal ICH
when diagnosed by fetal MRI. 
We performed a retrospective
study of all cases of fetal ICH diag-
nosed by fetal MRI at Children’s
National Prenatal Pediatrics Institute
from 2012 to 2020. Maternal char-
acteristics, prenatal and postnatal
imaging, ICH type, pregnancy out-
come, and infant/child developmental
progress were recorded. Abnormal
postnatal outcomes were categorized 
as: mild for hypertonia or physical/ 
occupational therapy without intel-
lectual disability or language delays; 
moderate for intermediate multi-
domain developmental delays; severe 
if non-ambulatory, non-verbal, or
signifcant intellectual disability.
We identifed 57 cases with ICH on
fetal MRI. The mean (SD) maternal 
age was 31.1(6.9) years, gestational age 
at fetal evaluation was 28.1(5.3) weeks, 
and birth gestational age was 38.2(1.3) 
weeks. Pregnancy outcomes consisted
of 75% (n=43) live births, 14% (n=8)
termination of pregnancy, and 11%
(n=6) intrauterine
demise (IUD). Of
FIGURE 1: Percentage of specifc pregnancy outcomes compared to ICH type on  
fetal MRI 
the ICH types, 81% Fetal MRI description of ICH location may aid 
(n=46) were intra-
ventricular hemor- in pregnancy outcome prediction and relates
rhage (IVH), 28% 
(n=16) were intrapa- to postnatal neurodevelopmental outcomes.renchymal and 16% 
normal in 57%, mildly abnormal in
24%, moderately abnormal in 14%,
and severely abnormal in 5%. From
unilateral IVH to parenchymal ICH,
there were 34% more patients with
(n= 9) were both. 
Ventriculomegaly
was the most common additional
fnding on fetal MRI, seen in 49% of 
patients.
From unilateral IVH to both
parenchymal and ventricular ICH,
there were 63% fewer live births
a nd 55% more IU D ( Fig u re 1).  
86% of live born infants were fol-
lowed clinically for 1.8 (1.6) years.
Neurodevelopmental outcome was
normal neurodevelopment (Figure
2). 30% required physical therapy
and 11% had epilepsy. In fve cases,
an etiolog y was identified; 3 had
abnormal placental findings and 2
had genetic findings (FNAIT and
COL41A mutation). 
Our findings demonstrate that
pregnancy and child outcomes fol-
lowing fetal ICH diagnosed on fetal 




   
 




      




















~ E 40 
e 8 
~ !, 30 
C: 0 
0 20 ..., 
C: 
~ 10 .... 
~ 
0 
Unilateral IVH Bilateral IVH Parenchymal ICH (± 
ICH type on fetal MRI IVH) 
■ Normal% 
■ Mildly Abnormal% 
■ Moderately Abnormal% 
Severely Abnormal % 
MRI have a wider spectrum of out-
comes than previously recognized.
Following fetal ICH, 75% of preg-
nancies result in live birth and 81%
of infants present with either normal 
neurodevelopment or mild neuro-
developmental delays that require
physical and/or occupational therapy.
Fetal MRI description of ICH
location may aid in pregnancy out-
come prediction and relates to post-
natal neurodevelopmental outcomes.
A lower proportion of adverse preg-
nancy outcomes was seen with uni-
lateral IVH, and this proportion
increased as the hemorrhage became 
more extensive (from unilateral to
bilateral) and involved diferent areas 
in the brain (from ventricles to paren-
chyma). The higher proportion of
normal neurodevelopment seen with 
parenchymal ICH may be a result
of the lower sample size of survivors 
seen with this hemorrhage. Our cur-
rent fndings help to provide data on 
fetal ICH and postnatal outcome that
can be used to improve counseling to 
expectant mothers. Further studies
FIGURE 2: Percentage of specifc neurodevelopmental outcomes compared to ICH 
type on fetal MRI 
should evaluate fetal ICH location, 2. Ghi T, Simonazzi G, Perolo A, et al. Out-
come of antenatally diagnosed intracranialsize, and timing in relation to prog-
hemorrhage: case series and review of the nosis for specifc postnatal outcomes. literature. Ultrasound Obstet Gynecol.
2003;22(2):121–130. doi:10.1002/uog.191 REFERENCES 
3. Sanapo L, Whitehead MT, Bulas DI, et al. 1. Elchalal U, Yagel S, Gomori JM, et al. Fetal
Fetal intracranial hemorrhage: role of fetalintracranial hemorrhage (fetal stroke):
MRI. Prenat Diagn. 2017;37(8):827–836.does grade matter? Ultrasound Obstet
doi:10.1002/pd.5096 Gynecol 2005; 26:233-43.  
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Endoscopic Gastrostomy Tube Placement: Do We Need to 
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Percutaneous endoscopic gastros-
tomy (PEG) has been widely used
for the long-term feeding of patients 
with a functional gastrointestinal
system that are otherwise unable to
intake solid or liquid food. There is
currently no consensus regarding
Our “NPO on-call” strategy led to a median tube feeds were held only
when the surgical team
time difference of 60 minutes between was at the bedside and
ready to begin the pro-
stopping tube feeds and insertion of the cedure. A tracheostomy 
possibility is supported, in part, by
the decreased NPO time required
in infants and children, even though 
their smaller stomachs and shorter
esophagi increase the possibility of
aspiration from a full stomach. Due
to this ambiguity, our study aims to 
investigate if using an “on-call” NPO 
strategy that minimizes the length
of holding tube feeds prior to PEG
placement is safe by recording gastric 
residual volume (GRV) prior to PEG 
tube placement and assessing peri-
procedural outcomes. We hypoth-
esize that there is less than 10ml
GRV and no complications related
to leakage of gastric contents using
this strategy. 
Here, we describe our experience 
using the “NPO on-call” strategy
for holding tube feeds prior to PEG 
tube placement for seventeen ICU
patients and describe
its safety. Continuous
endoscope for PEG. 
the length of time that tube feeds
should be held prior to bedside PEG 
tube placement in adult patients. The 
traditional dictum of holding tube
feeds (NPO) at midnight the night
prior to PEG placement is not borne 
out in the scientifc literature and may
put critically ill patients at risk of fur-
ther malnutrition due to interrupted 
enteral tube feeding.1 However, it
is not known whether withholding
tube feedings for a shorter time than 
the current standard is safe. This
was performed prior to
PEG. GRV and peri-
procedura l outcomes
were recorded. Patient
characteristics and results are sum-
marized in Table 1. The median time 
from stopping tube feeds to insertion 
of the endoscope was 60 minutes (30, 
115 IQR) and the median amount of 
GRV was 0 ml (0, 0 IQR). PEG was 
successfully performed on all patients
and there were no post-procedure
complications such as peritonitis or
aspiration. 
Enteral nutrition delivery is com-
monly interrupted in ICU patients,
often due to airway management,
digestive intolerance, and need for
diagnostic procedures.2 Moreover,
ICU patients are already in a state
of elevated energy expenditure due
to the metabolic needs of the body
under stress and critical il lness.1 
These factors together can lead to
large diferences between the caloric 
needs of patients and the calories
actually delivered to them.2 Low 
caloric intake, especially in ICU
patients, can lead to an increased risk 
of nosocomial bloodstream infec-
tions, hospital length of stay, and risk 
of ventilator-associated pneumonia.3,4 
Furthermore, caloric defcits in ICU 
patients are associated with the
occurrence of sepsis, adult respiratory
distress syndrome, and renal failure.5 
In order to reduce the occurrence of 
these risks, interruptions in enteral
nutrition need to be minimized. This 
understanding led to the adoption of 
“NPO on-call” withholding of tube
feeding at GW to minimize the time 
of interrupted feeding. 
Our “NPO on-call” strategy led
to a median time difference of 60
minutes between stopping tube feeds 
and insertion of the endoscope for
PEG. This is signifcantly less time
relative to the current standard prac-
tice of 8-16 hours. Given that these
seventeen patients also had a median 
GRV of 0 ml and no PPD-1 complica-
tions, our fndings highlight that the 
prolonged NPO time is not necessary
to performing endoscopy and PEG
placement safely.
In conclusion, our fndings indi-
cate that minimizing time for which 
tube feeds are held prior to PEG using
an “NPO on-call” strategy is a safe
practice and may prevent delay to
enteral nutrition.














     
 
 
TABLE: Patient characteristics and results 
BMI, body mass index; EGD, esophagogastroduodenoscopy; GRV, Gastric Residual Volume;  LOS, length of stay; NPO, nulla per os; PEG,
percutaneous endoscopic gastrostomy; PPD-1, post-procedure day 1; TFR, tube feed rate; 














60 M 26 25 50 10 0 Yes None 
73 F 28 6 18 40 719 0 Yes None 
83 F 23 5 11 42 100 0 Yes None 
45 F 21 5 12 54 155 0 Yes None 
52 M 35 9 15 130 60 200 Yes None 
71 M 51 1 14 54 30 0 Yes None 
59 F 31 7 19 50 10 0 Yes None 
62 F 27 2 28 58 20 0 Yes None 
76 M 32 3 8 40 525 0 Yes None 
62 M 33 1 14 42 11 0 Yes None 
94 F 19 9 16 54 98 5 Yes None 
57 F 24 3 11 50 210 0 Yes None 
31 M 24 5 5 30 115 5 Yes None 
77 M 34 5 8 58 80 0 Yes None 
62 F 27 2 25 58 50 0 Yes None 
74 M 36 7 15 29 44 0 Yes None 
79 F 28 7 15 45 45 0 Yes None 
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Association of Medication Mismanagement with Hospital-Related 
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TABLE 1: Comparison of baseline characteristics and outcome measures between PD 








Female % 443 (33 9%) 120 (31 8%) 0 460 
Age 74 7 ± 9 4 75 3 ± 9 7 0 315 
Length of Stay, days,
median (Q1, Q3) 
4 (2, 9) 10 (6, 20) <0 001 
30-day readmission 165 (12 6%) 96 (25 5%) <0 001 
Falls 24 (1 8%) 10 (2 7%) 0 320 
Delirium 44 (3 4%) 24 (6 4%) 0 009 
Parkinson’s disease (PD) is the second 
most common neurodegenerative dis-
ease, afecting over six million people 
worldwide.1 PD is defned by reduced 
dopaminergic neurotransmission in
the basal ganglia causing motor symp-
toms of tremor, rigidity, bradykinesia,
and postural instability, as well as
non-motor symptoms ranging from
autonomic dysfunction to cognitive
decline. PD requires complex medi-
cation management to maintain the 
delicate balance of striatal dopamine 
to treat motor and non-motor symp-
toms. Maintaining this regimen is
challenging in the inpatient setting.
Medication errors involving mistimed
PD medications and use of contrain-
dicated medications, such as neuro-
leptics or other dopamine-blocking
agents, are common in hospitalized
PD patients.2 Medication mistiming
has previously been shown to be
associated with longer lengths of stay 
and more complications.3 However,
limited data exists examining the
relationship between use of contra-
indicated medications and hospital
outcomes in the PD population. 
We aimed to investigate the inci-
dence of medication mismanage-
ment in hospitalized PD patients at
The George Washington University 
Hospital (GW Hospital) and explore 
the potential relationship of medi-
cation mismanagement on lengths
of stay, 30-day readmission rates,
falls, and delirium. We performed
a retrospective cha rt rev iew of 
PD patients admitted to the GW
Hospital between January 2015 and
January 2020. Lengths of stay, 30-day 
readmission rates, falls, and 
delirium incidences among
PD patients were compared 
to age (±2 years), sex, and
d ia g nosis-related g roup 
(DRG)-matched non-PD
controls. Subsequently, a
comprehensive chart review 
was done to identify specifc 
medication errors in the PD 
cohort. Medication errors
were grouped into 2 catego-
ries: mistimed administra-
tion of PD medications by
more than 30 minutes and
use of contraindicated medications.
Statistical analyses were performed to
determine whether medication errors
were associated with lengths of stay, 
30-day readmission rates, falls, and
delirium. 
Three hundred seventy seven PD 
patients were included in this study. 
The most common reasons for admis-
sion were degenerative nervous system
disorder, septicemia, and urinary tract
infection. Compared to controls, PD 
patients had approximately doubled 
lengths of stay (p<0.001), 30-day
readmission rates (p<0.001), and
delirium incidences (p=0.009). No
diferences were observed between
Our analysis suggests that medication 
mismanagement of PD patients at this 
center is prevalent, and the use of con-
traindicated medications is associated
with longer lengths of stay and higher 
delirium incidents.
PD and control cohorts regarding
falls (p=0.320) (Table 1). Medication
mistiming occurred in 88.1% of PD
patients. 14% of PD patients were
prescribed a contraindicated medica-
tion, and those patients experienced 
significantly longer lengths of stay
(p<0.001) and had signifcantly more 











































delirium incidences (p=0.001). No sta-
tistically signifcant diferences were
observed in 30-day readmission rates 
TABLE 2: Comparison of outcome measures in PD patients who did or did not receive 
contraindicated medications 
(p=0.248) or falls (p=0.408) (Table 2). 
The most commonly used contrain-
dicated medications were haloperidol
(38.18%), prochlorperazine (14.55%),
and metoclopramide (12.73%). 
Our analysis suggests that medica-
tion mismanagement of PD patients 
at this center is prevalent, and the
use of contraindicated medications
is associated with longer lengths of
stay and higher delirium incidents.
This supports several reports in
the literature regarding the fre-
quency of medication mismanage-
ment in hospitalized PD patients
and its potential impact.2-5 Further 
analysis will need to be conducted
to specifically assess the impact of
medication mistiming on lengths of
stay, 30-day readmission rates, and
hospital complications, as this seems 
to be a common occurrence. Notably, 
our study could not assess whether
increased delirium incidences in
the PD cohort were a result of using 
contraindicated medications or if con-
traindicated medications were used







Length of Stay, days,
median (Q1, Q3) 
10 (5, 18) 16 (8, 28) <0 001 
30-day readmission 90 (26 5%) 10 (20 6%) 0 248 
Falls 10 (2 9%) - 0 408 
Delirium 16 (4 7%) 10 (18 2%) 0 001 
study represents an important step in 
addressing the quality of care hospi-
talized PD patients receive and serves
as a starting point for creating and
implementing mitigation strategies
to improve the care of PD patients. 
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Atopic Dermatitis is Associated with Multiple 
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Atopic dermatitis (AD) is a chronic,
infammatory skin disease associated
with intense itch, sleep disturbance,
psychosocial distress, and symptoms
of anxiety and depression.1 All of these
sequelae of AD may negatively impact
the emotional health and social func-
tioning in children, and ultimately lead
to behavioral problems. We aimed to
understand the association between
AD and aberrant childhood behaviors.
Data were analyzed from the
Fragile Families and Child Wellbeing
Study, a longitudinal birth cohort
study of 4898 children in 20 U.S.
cities.2 AD was associated with the
≥75th percentile of mean behavioral
scores at 5 years (multivariable logistic
regression; adjusted odds ratio [95%
confdence interval]: 1.51 [1.18-1.93]),
9 years (1.62 [1.32-1.99]) and 15 years
(1.44 [1.17-1.76]).
There was signifcantly increased 
behavioral problems at age 15 when
AD persisted at ages 5, 9 and 15
(Poisson regression; adjusted risk
ratio [CI95]: 1.17 [1.01-1.35]), ages 5
and 15 (1.33 [1.08-1.63]) and ages 9
and 15 (crude risk ratio [CI95]: 1.27
[1.03-1.56]). AD was associated with
12 aberrant behaviors, particularly
fghting (repeated measures logistic
regression; adjusted odds ratio [CI95]:
1.40 [1.15-1.70]), physically attacking 
people (1.38 [1.09-1.76]), being sullen
(1.31 [1.15-1.49]), worrying (1.41 [1.23-
1.61]), and threatening others (1.35
[1.08-1.70]). AD at age 15 was associ-
ated with ≥ 75th percentile of the
Child Behavior Checklist (CBCL)
subscales: anxious/depressed (aOR
[CI95]: 1.44 [1.16-1.78]), withdrawn
(1.40 [1.11-1.77]), attention problems
(1.33 [1.09-1.63]), social problems (1.39
[1.13-1.72]) and aggressive (1.49 [1.22-
1.82]). Significant two-way interac-
tions were present between AD and 
sleep as predictors of underactivity
(4.31 [3.06-6.08]), being threatening
(aOR [CI95]: 3.42 [2.20-5.34]), being
sullen (3.86 [2.74-5.43]) and nervous-
ness (4.56 [3.29-6.32]). 
Conclusion: Childhood AD, par-
ticularly persistent disease with sleep 
disturbances, was associated with a
wide range of behavioral problems in 
US children and/or adolescents. 
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Agenesis of the corpus callosum
(ACC), complete or partial, is one
of the most common brain malfor-
mations, occurring in 1:4000 live
births, and results in a wide spectrum 
of clinical outcomes.1 Fetal MRI 
is increasingly utilized to discern
corpus callosum abnormalities that
are unable to be fully assessed with
ultrasonography.2 This study aims
to describe the spectrum of fetal
brain abnormalities in ACC cases
diagnosed by fetal MRI,determine
the frequency of postnatal confrma-
tion by brain MRI of fetal cases, and 
understand pregnancy and postnatal
outcomes. 
Methods: Patient medical records 
from Children’s National Hospital’s
Cerner database from Jan. 1, 2012 to 
June 30, 2019 with a referral for a pos-
sible brain abnormality (ACC, cavum
septum pellucidum abnormality, and/ 
or ventriculomegaly), prenatal neuro-
logical consultation, complete fetal
MRI, and confirmed ACC (partial
or complete type) on imaging were
included. Data on maternal medical
and obstetric history, prenatal testing,
prenatal imaging, labor and delivery, 
neonatal birth history, and postnatal 
evaluations/outcomes were recorded.
Cases were defned as isolated if ACC 
TABLE: Participant Characteristics 
was the only brain fnding. Cases were
defned as complex if there were sig-
nifcant brain fndings in addition to 
ACC: ventriculomegaly/hydroceph-
alus, posterior fossa malformation,
or malformation of cortical develop-
ment. Each case was categorized as
partial or complete ACC and isolated 
or complex ACC, and group compari-
sons on outcomes were analyzed. 
Results: We evaluated 127 pregnant
women-fetal dyads by fetal MRI at
25.8 ± 5.3 weeks gestation. Forty-fve 
(36%) had isolated-complete ACC,
17 (13%) had isolated-partial ACC, 46 
(36%) had complex-complete ACC,
and 19 (15%) had complex-partial ACC
based on fetal MRI. 
Pregna ncy outcome was l ive 









Mean 38 34 4 36 4 
≤30 2 3 5 
31-40 2 4 6 
>40 6 1 7 
Legal Status 
Naturalized 1 1 2 
Permanent Resident 0 5 5 
Work Permit 3 1 4 
Overseas Born Citizen 0 1 1 
Undocumented 6 0 6 
Time in US (years) 
Mean 20 11 9 16 4 
County 
LA 5 5 10 
OC 5 3 8 
Undocumented family or friends 
10 (100%) 3 (37 5%) 13 (72 2%) 
and intrauterine demise in three.
Seventy-one of 75 live births had
postnatal evaluations; 59 had postnatal
imaging (56 brain MRI; three head
ultrasound). In 40 of 59 (68%) cases,
postnatal imaging confirmed the
prenatal ACC fnding; 19 cases had dif-
fering prenatal and postnatal imaging
results. In them, 12 were identifed as
isolated-complete ACC prenatally and
were changed to complex-complete 
(n=10) or isolated-partial (n=2) ACC
postnatally. Two cases were identifed
as complex-complete prenatally and
were changed to isolated-complete
ACC postnatally. Children with
partial or complete ACC had similar
rates of communication and/or motor
Continued on p. 78 
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Continued fom p. 77 
delays (44%); however, seizures were
more common in partial ACC cases
(26% vs. 17%). Complex ACC cases had
poorer outcomes than isolated ACC
cases, with complex cases having more
delivery complications (44% vs. 16%),
NICU admissions (69% vs. 28%), dys-
morphisms in postnatal evaluations
(67% vs. 27%), hearing abnormalities
(20% vs. 5%), seizures (33% vs 11%), and
hydrocephalus (26% vs 0%). 
Conclusions: Children with com-
plex ACC demonstrate a poorer neu-
rologic outcome compared to children
with isolated ACC. Fetal MRI can
help to differentiate isolated and
complex abnormalities of the corpus 
callosum and is a useful tool to guide 
prenatal counseling and postnatal
neurologic care. 
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in California 1983–2003: a population-
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A, Sagies TL, et al. (2016). Outcomes
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The latest threat to global health is
the ongoing outbreak of Coronavirus
Disease 2019 (COVID-19). Previous
studies have made it increasingly clear
that the innate immune system is a
critical player in a patient’s response 
to COVID-19 infection. Further, the 
disease-causing virus SARS-CoV-2
is a positive-sense RNA virus and
is therefore, speculated to be rec-
ognized by RNA-sensing pattern
recognition receptors of the innate
immune system. Finally, cytokine
levels of IL1-b and LDH are found to 
be elevated in patients with COVID-
19, which are cytosolic proteins that 
require release by infammasome acti-
vation and membrane rupture, respec-
tively.1 In this study, our lab shows
that excessive caspase-1 inflamma-
some activation contributes to infam-
mation in the setting of COVID-19. 
Blood samples were obtained
from patients that tested positive for 
COVID-19 by RT-PCR as well as
samples from COVID-19 negative,
FIGURE 1: Caspase-1 expression as % positive and mena fuorescence intensity 
(MFI) in CD3-negative (B+NK cells)  CD3+ and CD3+CD4+ cells  COVID-19 patients 
show increased expression both at baseline as well as after nigericin stimulation with 
p< 0001  
healthy controls. Peripheral blood
mononuclear cells (PBMCs) were
isolated from whole blood using a
ficoll gradient and centrifugation,
and subsequently stained with a
mix of fuorescent-conjugated anti-
bodies. A FAM-FLICA Caspase-1
and 3/7 Assay Kit was used to assess 
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caspase expression by f low cytom-
etry. Samples were run on the Canto 
Cytometer and files were analyzed
using FCS Express software. 
Our experiments found that cas-
pase-1 expression was elevated in
COVID-19 patients compared to
healthy controls, with highest levels
seen in ICU patients compared to non-
ICU patients (Figure 1). In order to
show that there is distinct elevation in
the pyroptotic pathway without eleva-
tion in the other caspases involved in
the programmed apoptotic pathway,
we also looked at caspase-3 and cas-
pase-7 expression in isolated PBMCs.
Indeed, there was no statistical difer-
ence in expression of these proteins
between COVID-19 patients and
healthy controls (Figure 2). 
O u r f i nd i n g s  i nd icate  t h at 
COVID-19 patients may have exces-
sive activation of pyroptosis through 
the caspase-1 infammasome. Future 
experiments aim to better under-
stand the consequence of this aber-
rant inf lammasome activation on
the immune system and possibly
on red blood cell function. Our lab
has performed in vitro experiments
on whole blood using a pan-caspase
inhibitor to show that capase-1 levels 
can successfully be attenuated and
hopes to explore this drug in a phase 
I clinical trial for the treatment of
patients with COVID-19. 
FIGURE 2:  Caspase-3/7 expression as % positive in CD3+CD8+ and CD3+CD4+ 
cells  COVID-19 patients show no signifcant difference in expression of caspase 3/7,
which are mediators of apoptosis 
REFERENCE:
1. Huang C, Wang Y, Li X, Ren L, Zhao J, 
et al. (2020). Clinical features of patients 
infected with 2019 novel coronavirus in
Wuhan, China. The Lancet, 395(10223),
497-506. 





















































 Translational Research 
An Anatomical Study of the Foramen of Monro: Implications in 
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For pineal tumors presenting with
hydrocephalus, simultaneous endo-
scopic third ventriculostomy (ETV) 
and tumor biopsy is commonly used 
as the initial step in management.1, 2, 
4, 5 To analyze the restriction which
the foramen of Monro poses to this
FIGURE 1: Measuring the dimensions of the Foramen of Monro  In this example, the 
short axis is measured (a) To start the measurement, a preliminary ruler was implanted 
using the top-down view on the foramen  Inset—orientation view of the top-down view 
along the axis of the foramen This ruler was then examined for placement and accuracy 
in multiple angles in 3D space, with the ventricle and foramen frst as empty spaces and 
then as a solid “cast” (b and c)  Every foramen was measured in this fashion and data 
recorded only when confrmation of the correct and precise placement of the ruler was 
obtained (d)  
procedure, one must start with a
detailed description of the microsur-
gical anatomy of the foramen in living
subjects. However, the orientation
and shape of the foramen of Monro
make this description difcult with
conventional imaging techniques.3, 5 
Method: Virtual reality tech-
nology was applied to MRIs of 30
living subjects without hydroceph-
alus, as well as to MRIs of 16 patients 
with hydrocephalus, to generate
precise anatomica l models with
sub-millimeter accuracy. The mor-
phometry of the foramen of Monro
was studied in each group. In addi-
tion, displacement of the margins of 
the foramen was studied in detail for 
simultaneous ETV and pineal tumor 
biopsy through a single burr hole. 
Results: In 30 normal subjects, the 
foramen of Monro had oval-shaped
openings averaging 5.23 mm2. The
foramen was larger in people above
age 55 (average 7.19mm2 over 55,
versus 3.28 mm2 under 55, p = 0.007) 
and larger on the left side compared 
to the right in 73% of study subjects 
(average 5.93 mm2 left, versus 4.52
mm2 right, p = 0.002). For 16 patients 
with clinical presentation of hydro-
cephalus, the average opening was
32.6 mm2. Simulated single burr
hole simultaneous ETV and pineal
tumor biopsy was performed in 10
specimens. Average displacement of
the posterior and anterior margins of 
the foramen was 5.71 mm and 5.76 mm,
respectively. However, maximum dis-
placement reached 9.3 mm posteriorly
and 10 mm anteriorly. 
Conclusions:  T he fora men of 
Monro is an oval-shaped cylinder that
changes in size and orientation in the 





























applied to all patients regardless of
foramen and tumor size, ETV/biopsy 
can displace structures around the
Foramen of Monro up to 1 cm, which 
can potentially lead to neurological
damage. Careful pre-operative assess-
ment is critical to determine if a single
burr hole approach is safe. 
REFERENCES: 
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endoscopic third ventriculostomy and
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34:1335–1344 
2. A hmed AI, Zaben MJ, Mathad N V,
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and third ventriculostomy for the man-
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point for endoscpic third ventriculos-
tomy: eva luation of 53 patients with
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116:1153–1157 
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U-W (2011) Single burr hole endoscopic
biopsy with third ventriculostomy –
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FIGURE 2: Generating the trajectories and measuring the displacement of the
Foramen of Monro  Ideal trajectories extended from the pineal tumor and tuber cinereum
(a), through the center of the foramen of Monro (b), to the surface (c) The study entry (SE)
was then calculated by fnding the midpoint of the exits points of the ideal trajectories
(c)  Biopsy (blue) and ETV (green) trajectories were then projected from the SE back to
the targets (d)  Examining the foramen of Monro with these trajectories in close-up, the
anterior displacement (X) and posterior displacement (Y) were measured (e)  
5. Morgenstern PF, Osbun N, Schwartz TH, 
Greenfeld JP, Tsiouris AJ, Souweidane
M M (2011) Pineal region tumors: an
optimal approach for simultaneous endo-
scopic third ventriculostomy and biopsy. 
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